<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><front><journal-meta><journal-id journal-id-type="nlm-ta">Med Hypotheses</journal-id><journal-id journal-id-type="iso-abbrev">Med Hypotheses</journal-id><journal-id journal-id-type="pmc-domain-id">3815</journal-id><journal-id journal-id-type="pmc-domain">pheelsevier</journal-id><journal-title-group><journal-title>Medical Hypotheses</journal-title></journal-title-group><issn pub-type="ppub">0306-9877</issn><issn pub-type="epub">1532-2777</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>Elsevier - PMC COVID-19 Collection</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC7467030</article-id><article-id pub-id-type="pmcid-ver">PMC7467030.1</article-id><article-id pub-id-type="pmcaid">7467030</article-id><article-id pub-id-type="pmcaiid">7467030</article-id><article-id pub-id-type="pmid">33254543</article-id><article-id pub-id-type="doi">10.1016/j.mehy.2020.110237</article-id><article-id pub-id-type="pii">S0306-9877(20)31946-0</article-id><article-id pub-id-type="publisher-id">110237</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Hypotheses about sub-optimal hydration in the weeks <italic toggle="yes">before</italic> coronavirus disease (COVID-19) as a risk factor for dying from COVID-19</article-title></title-group><contrib-group><contrib contrib-type="author" id="au005"><name name-style="western"><surname>Stookey</surname><given-names initials="JD">Jodi D.</given-names></name><xref rid="af005" ref-type="aff">a</xref><xref rid="cor1" ref-type="corresp">&#8270;</xref></contrib><contrib contrib-type="author" id="au010"><name name-style="western"><surname>Allu</surname><given-names initials="PKR">Prasanna K.R.</given-names></name><xref rid="af010" ref-type="aff">b</xref></contrib><contrib contrib-type="author" id="au015"><name name-style="western"><surname>Chabas</surname><given-names initials="D">Dorothee</given-names></name><xref rid="af015" ref-type="aff">c</xref></contrib><contrib contrib-type="author" id="au020"><name name-style="western"><surname>Pearce</surname><given-names initials="D">David</given-names></name><xref rid="af020" ref-type="aff">d</xref></contrib><contrib contrib-type="author" id="au025"><name name-style="western"><surname>Lang</surname><given-names initials="F">Florian</given-names></name><xref rid="af025" ref-type="aff">e</xref></contrib><aff id="af005"><label>a</label>Hydration Science Lab, College of Health Solutions, Arizona State University, Phoenix, AZ, USA</aff><aff id="af010"><label>b</label>Section on Integrative Physiology and Metabolism, Joslin Diabetes Center, Harvard Medical School, Boston, USA</aff><aff id="af015"><label>c</label>Neuroesthetics, San Francisco, CA, USA</aff><aff id="af020"><label>d</label>Department of Medicine, University of California, San Francisco, CA, USA</aff><aff id="af025"><label>e</label>Department of Physiology, Eberhard Karls University, Tubingen 72074, Germany</aff></contrib-group><author-notes><corresp id="cor1"><label>&#8270;</label>Corresponding author at: 631 Lyon St, San Francisco, CA 94117, United States.</corresp></author-notes><pub-date pub-type="ppub"><month>11</month><year>2020</year></pub-date><pub-date pub-type="epub"><day>2</day><month>9</month><year>2020</year></pub-date><volume>144</volume><issue-id pub-id-type="pmc-issue-id">364373</issue-id><fpage>110237</fpage><lpage>110237</lpage><history><date date-type="received"><day>24</day><month>6</month><year>2020</year></date><date date-type="rev-recd"><day>20</day><month>8</month><year>2020</year></date><date date-type="accepted"><day>30</day><month>8</month><year>2020</year></date></history><pub-history><event event-type="pmc-release"><date><day>02</day><month>09</month><year>2020</year></date></event><event event-type="pmc-live"><date><day>03</day><month>09</month><year>2020</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-11-01 19:25:26.020"><day>01</day><month>11</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>&#169; 2020 The Authors</copyright-statement><copyright-year>2020</copyright-year><license><license-p>Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="main.pdf"/><abstract id="ab005"><p>To address urgent need for strategies to limit mortality from coronavirus disease 2019 (COVID-19), this review describes experimental, clinical and epidemiological evidence that suggests that chronic sub-optimal hydration in the weeks <italic toggle="yes">before</italic> infection might increase risk of COVID-19 mortality in multiple ways. Sub-optimal hydration is associated with key risk factors for COVID-19 mortality, including older age, male sex, race-ethnicity and chronic disease. Chronic hypertonicity, total body water deficit and/or hypovolemia cause multiple intracellular and/or physiologic adaptations that preferentially retain body water and favor positive total body water balance when challenged by infection. Via effects on serum/glucocorticoid-regulated kinase 1 (SGK1) signaling, aldosterone, tumor necrosis factor-alpha (TNF-alpha), vascular endothelial growth factor (VEGF), aquaporin 5 (AQP5) and/or Na<sup>+</sup>/K<sup>+</sup>-ATPase, chronic sub-optimal hydration in the weeks <italic toggle="yes">before</italic> exposure to COVID-19 may conceivably result in: greater abundance of angiotensin converting enzyme 2 (ACE2) receptors in the lung, which increases likelihood of COVID-19 infection, lung epithelial cells which are pre-set for exaggerated immune response, increased capacity for capillary leakage of fluid into the airway space, and/or reduced capacity for both passive and active transport of fluid out of the airways. The hypothesized hydration effects suggest hypotheses regarding strategies for COVID-19 risk reduction, such as public health recommendations to increase intake of drinking water, hydration screening alongside COVID-19 testing, and treatment tailored to the pre-infection hydration condition. Hydration may link risk factors and pathways in a unified mechanism for COVID-19 mortality. Attention to hydration holds potential to reduce COVID-19 mortality and disparities via at least 5 pathways simultaneously.</p></abstract><kwd-group id="kg005"><title>Keywords</title><kwd>Chronic hydration</kwd><kwd>Hypertonicity</kwd><kwd>COVID-19</kwd><kwd>Mortality</kwd><kwd>ACE2 receptors</kwd><kwd>VEGF</kwd><kwd>AQP5</kwd><kwd>SGK1</kwd><kwd>Saliva osmolality</kwd><kwd>Drinking water intervention</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s0005"><title>Background</title><p id="p0005">There is an urgent need for strategies to limit mortality from coronavirus disease 2019 (COVID-19). Coronavirus is expected to infect up to 70% of the world&#8217;s population and kill millions of people <xref rid="b0005" ref-type="bibr">[1]</xref>. To date, the main public health strategy for limiting mortality, to reduce exposure to the virus via physical distancing, carries tremendous economic costs <xref rid="b0010" ref-type="bibr">[2]</xref> and may create COVID-19 disparities, as not everyone can telecommute for work or afford to shelter in place <xref rid="b0015" ref-type="bibr">[3]</xref>. The main treatment strategy for limiting mortality involves ventilators, which may not be available and accessible in adequate quantities <xref rid="b0020" ref-type="bibr">[4]</xref>. To address need for strategies that are less costly, more equitable, and more accessible, this paper describes potential causal paths from sub-optimal hydration <italic toggle="yes">before</italic> COVID-19 infection to increased morbidity and mortality. The hypothesized mechanisms suggest potential for free or low-cost, globally applicable drinking water interventions and hydration-informed treatment (e.g. hypertonic resuscitation) to limit COVID-19 mortality.</p><sec id="s0010"><title>Why do people die from COVID-19?</title><p id="p0010">COVID-19 triggers an immune response in the lungs that is described as a &#8220;cytokine storm&#8221; in the lay press and acute respiratory distress syndrome (ARDS) in the scientific literature <xref rid="b0025" ref-type="bibr">[5]</xref>. &#8220;Inflammation spikes, and fluid and dying cells fill the lung sacs, essentially drowning the patient <xref rid="b0030" ref-type="bibr">[6]</xref>.&#8221; The inflammation &#8220;makes the membranes between the air sacs and blood vessels more permeable, which can fill the lungs with fluid&#8230;In severe cases, you basically flood your lungs and you can&#8217;t breathe <xref rid="b0030" ref-type="bibr">[6]</xref>.&#8221; Death from ARDS is strongly associated with positive total body water (TBW) balance, i.e. <italic toggle="yes">body water retention</italic>
<xref rid="b0035" ref-type="bibr">[7]</xref> (see <xref rid="f0005" ref-type="fig">Fig. 1</xref>
).<fig id="f0005" position="float" orientation="portrait"><label>Fig. 1</label><caption><p>Reproduced with permission from Rahmel et al <xref rid="b0035" ref-type="bibr">[7]</xref>. Mean cumulative fluid balance with 95% CI for survivors and non-survivors of ARDS until ICU day 30.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="gr1_lrg.jpg"/></fig></p></sec><sec id="s0015"><title>Risk factors for COVID-19 death</title><p id="p0015">Death from COVID-19 is strongly associated with older age, male sex, and age-related chronic health conditions <xref rid="b0040" ref-type="bibr">[8]</xref>, <xref rid="b0045" ref-type="bibr">[9]</xref>, <xref rid="b0050" ref-type="bibr">[10]</xref>. The United States (US) Centers for Disease Control (CDC) highlights the following risk factors: residence in a nursing home or long-term care facility, chronic lung disease or moderate to severe asthma, serious heart conditions, severe obesity (body mass index&#160;&gt;&#160;40), diabetes, renal failure, liver disease, and/or weakened immune system due to cancer treatment, smoking, bone marrow or organ transplantation, immune deficiencies, poorly controlled HIV or AIDS, and prolonged use of corticosteroids and other immune weakening medications <xref rid="b0050" ref-type="bibr">[10]</xref>. In the US and United Kingdom (UK), consistent with obesity, diabetes, cardiovascular and chronic kidney disease disparities, ethnic minorities are at increased risk of dying from COVID-19 <xref rid="b0055" ref-type="bibr">[11]</xref>, <xref rid="b0060" ref-type="bibr">[12]</xref>.</p><p id="p0020">Although not specified on the CDC&#8217;s list of risk factors <xref rid="b0050" ref-type="bibr">[10]</xref>, given the ARDS literature (e.g. Rahmel et al. <xref rid="b0035" ref-type="bibr">[7]</xref>), a propensity to retain body water when stressed or challenged is partially recognized as a risk factor for COVID-19 ARDS death. Recommendations for COVID-19 ARDS treatment explicitly aim to achieve a <italic toggle="yes">negative</italic> fluid balance of 0.5&#8211;1.0 L/d <xref rid="b0065" ref-type="bibr">[13]</xref>. This paper posits that attention to hydration may not only increase the success of treatment for ARDS but may also prevent the development of ARDS and positive fluid balance during COVID-19 infection, in the first place.</p></sec></sec><sec id="s0020"><title>Hypotheses</title><sec id="s0025"><title>Hypothesized mechanism</title><p id="p0025">This paper hypothesizes that, compared to people who survive COVID-19, people who die from COVID-19 have too much fluid accumulating in their lungs, in part because of chronic suboptimal hydration <italic toggle="yes">before</italic> infection with COVID-19. Chronic <underline>hyper</underline>tonic stress causes a wide variety of metabolic and physiologic adaptations throughout the body <xref rid="b0070" ref-type="bibr">[14]</xref>, which alter intracellular composition and response to subsequent <underline>hypo</underline>-osmotic challenge. Infection triggers an inflammatory response which signals body water retention and vessel dilation, creating relatively hypotonic conditions.</p><p id="p0030">Chronic hypertonicity, TBW deficit and/or hypovolemia in the weeks <italic toggle="yes">before</italic> COVID-19 infection are hypothesized to result in one or more adaptations, including:<list list-type="simple" id="l0005"><list-item id="o0005"><label>&#8226;</label><p id="p0035">Greater abundance of angiotensin converting enzyme 2 (ACE2) receptors in the lung, which increases likelihood of COVID-19 infection.</p></list-item><list-item id="o0010"><label>&#8226;</label><p id="p0040">Lung epithelial cells which are pre-set for exaggerated immune response.</p></list-item><list-item id="o0015"><label>&#8226;</label><p id="p0045">Increased capacity for capillary leakage of fluid into the airway space.</p></list-item><list-item id="o0020"><label>&#8226;</label><p id="p0050">Reduced capacity for active transport of fluid out of the airways.</p></list-item><list-item id="o0025"><label>&#8226;</label><p id="p0055">Reduced capacity for passive transport of fluid out of the airways.</p></list-item></list>
</p><p id="p0060">Fluid accumulating in the lungs results from an imbalance between passive and active forces driving fluid into the airspaces and mechanisms removing fluid from the airspace <xref rid="b0075" ref-type="bibr">[15]</xref>, <xref rid="b0080" ref-type="bibr">[16]</xref>. The multiplicity of factors influencing the balance of forces suggests need for intervention strategies that attend to multiple factors, simultaneously.</p></sec></sec><sec id="s0030"><title>Evidence motivating the hypotheses</title><sec id="s0035"><title>Overview</title><p id="p0065">The rationale begins by linking the CDC&#8217;s list of risk factors for COVID-19 death with increased likelihood of suboptimal hydration, expressed in terms of hypertonicity, TBW deficit and/or hypovolemia. Suboptimal hydration is, next, linked with each of the adaptations, listed above, by experimental, clinical, and epidemiological evidence. Metabolic intermediates or pathways that mediate effects of suboptimal hydration are identified. Experiments and clinical trials that intervene against these mechanisms and increase survival from ARDS are described.</p></sec><sec id="s0040"><title>Risk factors for COVID-19 death are associated with indices of suboptimal hydration</title><p id="p0070">Hypertonicity, TBW deficit and/or hypovolemia are prevalent among people who are at increased risk for COVID-19 death. In population-representative datasets, a majority of older adults have plasma hypertonicity <xref rid="b0085" ref-type="bibr">[17]</xref>, <xref rid="b0090" ref-type="bibr">[18]</xref>. In the US, hypertonicity is significantly more frequent among males than females <xref rid="b0085" ref-type="bibr">[17]</xref> and among Black or African Americans and Hispanics compared to Asians (78&#8211;79% vs 55%) <xref rid="b0090" ref-type="bibr">[18]</xref>. Hypovolemia is common among residents of nursing home or long-term care facilities <xref rid="b0095" ref-type="bibr">[19]</xref>, <xref rid="b0100" ref-type="bibr">[20]</xref>.</p><p id="p0075">Hypertonicity is associated with chronic disease risk factors for COVID-19 death. The prevalence of hypertonicity in non-acutely ill US adults ages 51&#8211;70&#160;years who have obesity, high waist circumference, insulin resistance, diabetes, hyperglycemia, glycosylated hemoglobin, dyslipidemia, hypertension and/or metabolic syndrome is 73%, compared to 56% among individuals without any of the listed conditions, in the same age group <xref rid="b0090" ref-type="bibr">[18]</xref>. Systematic review of observational studies suggests that hypernatremia is consistently associated with metabolic syndrome <xref rid="b0105" ref-type="bibr">[21]</xref>. Animal models and observational studies implicate hypertonicity and the vasopressin-hydration system in the etiology of chronic kidney disease <xref rid="b0110" ref-type="bibr">[22]</xref>. Hypovolemia is an established risk factor for renal failure in the ICU <xref rid="b0115" ref-type="bibr">[23]</xref>.</p><p id="p0080">Beyond older age, male sex, race-ethnicity and metabolic syndrome, hypertonicity and/or hypovolemia are also associated with asthma, liver disease, and impaired immune function, other risk factors for COVID-19 death highlighted by the CDC <xref rid="b0050" ref-type="bibr">[10]</xref>. Bronchial hyperresponsiveness in asthma is associated with hypertonicity <xref rid="b0120" ref-type="bibr">[24]</xref>. The pathogenesis of cirrhosis involves vasopressin/antidiuretic hormone, low effective circulatory volume and retention of sodium and water <xref rid="b0125" ref-type="bibr">[25]</xref>. Hypertonicity suppresses innate and adaptive immune responses <xref rid="b0130" ref-type="bibr">[26]</xref>. For US adults ages 50&#8211;70&#160;years, hypertonicity doubles the risk of all-cause mortality within 3 to 6&#160;years <xref rid="b0090" ref-type="bibr">[18]</xref> and has been proposed as a biomarker of general frailty <xref rid="b0135" ref-type="bibr">[27]</xref>.</p></sec><sec id="s0045"><title>Suboptimal hydration causes body water retention</title><p id="p0085">Hypertonicity, TBW deficit, and hypovolemia trigger changes in metabolism and physiology that favor cell water retention <xref rid="b0140" ref-type="bibr">[28]</xref> and TBW retention <xref rid="b0145" ref-type="bibr">[29]</xref>. Responses to acute and chronic hypertonicity are distinct <xref rid="b0150" ref-type="bibr">[30]</xref>. Multiple metabolic and physiologic responses co-occur impacting multiple pathways and organ systems simultaneously <xref rid="b0070" ref-type="bibr">[14]</xref>, <xref rid="b0150" ref-type="bibr">[30]</xref>. In free-living individuals, under conditions of daily life, adaptation to chronic hypertonicity may take weeks <xref rid="b0155" ref-type="bibr">[31]</xref>, <xref rid="b0160" ref-type="bibr">[32]</xref>.</p><sec id="s0050"><title>Acute suboptimal hydration</title><p id="p0090">Acute extracellular hypertonicity causes water to shift out of cells following the osmotic gradient via aquaporin channels. The cell shrinkage increases intracellular solute concentrations, which activate the Na<sup>+</sup>,K<sup>+</sup>-ATPase, Na<sup>+</sup>,K<sup>+</sup>,2Cl<sup>-</sup> co-transporter and the Na<sup>+</sup>/H<sup>+</sup>&#160;exchanger, which couple to Cl<sup>-</sup>/H2CO3, to enhance cellular osmolarity and restore cell volume <xref rid="b0165" ref-type="bibr">[33]</xref>.</p><p id="p0095">At the whole-person level, acute hypertonic shrinkage of osmoreceptor cells and/or hypovolemia activate the hypothalamic&#8211;pituitaryadrenal (HPA) axis and renin-angiotensin-aldosterone system (RAAS). Acute hypertonicity triggers release of arginine vasopressin, also known as antidiuretic hormone, which stimulates thirst and signals the kidney to concentrate urine and reduce urine volume. Acute hypovolemia triggers the kidney to produce renin, which stimulates the conversion of angiotensinogen to angiotensin 1 (Ang I) in the liver and the conversion of Ang I to angiotensin II (Ang II) by the angiotension-converting enzyme (ACE) in multiple organs, including the lung <xref rid="b0170" ref-type="bibr">[34]</xref>. Ang II causes vasoconstriction and secretion of antidiuretic hormone and aldosterone <xref rid="b0170" ref-type="bibr">[34]</xref>. Aldosterone binds to mineralocorticoid receptors and stimulates renal and intestinal sodium reabsorption by upregulating ENaC and Na<sup>+</sup>, K<sup>+</sup>-ATPase.</p></sec><sec id="s0055"><title>Chronic suboptimal hydration</title><p id="p0100">At the cell level, chronic hypertonicity shifts metabolism to favor pathways that accumulate metabolic end-products (osmolytes) of low molecular weight inside the cell. The increased osmolyte concentrations create an osmotic gradient that drives water into the cell. Hypertonic conditions alter the expression of multiple genes. Hypertonicity activates tonicity-responsive enhancer binding protein (TonEBP), also known as nuclear factor of activated T cells (NFAT5), which coordinates increases in the expression of organic osmolyte transporters and enzymes such as aldose reductase (AR), betaine/GABA transporter (BGT1), sodium myoinositol transporter (SMIT) and taurine transporter (TauT) <xref rid="b0165" ref-type="bibr">[33]</xref>. Hypertonic conditions induced by high-salt diet decrease expression of renal renin and angiotensinogen-mRNAs compared to normal- and low-salt diets <xref rid="b0175" ref-type="bibr">[35]</xref>. Hypertonic conditions reduce expression of the mineralocorticoid receptor that mediates aldosterone effects <xref rid="b0180" ref-type="bibr">[36]</xref>. Chronic hypertonicity and hypovolemia increase expression of vascular endothelial growth factor (VEGF) <xref rid="b0185" ref-type="bibr">[37]</xref>, <xref rid="b0190" ref-type="bibr">[38]</xref>.</p><p id="p0105">At the physiological level, hypertonicity alters the levels and/or activity of hormones that depend on cell volume, such as insulin <xref rid="b0195" ref-type="bibr">[39]</xref>, <xref rid="b0070" ref-type="bibr">[14]</xref>, and/or that regulate TBW balance, such as aldosterone. Experiments in animals and healthy humans show that hypertonicity induced by high salt diet or hypertonic infusion reduces plasma aldosterone <xref rid="b0175" ref-type="bibr">[35]</xref>, <xref rid="b0200" ref-type="bibr">[40]</xref>, <xref rid="b0205" ref-type="bibr">[41]</xref>, <xref rid="b0210" ref-type="bibr">[42]</xref>, <xref rid="b0215" ref-type="bibr">[43]</xref>. Crossover experiments in healthy volunteers report that infusion of 25&#160;ml/kg of a relatively hypertonic solution (osmolarity 614&#160;mOsm/l; tonicity 373&#160;mOsm/l) significantly decreases plasma aldosterone relative to the same volume of a hypotonic solution (osmolarity 447&#160;mOsm/l; tonicity 169&#160;mOsm/l) <xref rid="b0215" ref-type="bibr">[43]</xref>. In controlled experiments in healthy humans, hypertonic saline infusion decreases plasma aldosterone and free water clearance <xref rid="b0210" ref-type="bibr">[42]</xref>, <xref rid="b0220" ref-type="bibr">[44]</xref>.</p><p id="p0110">In healthy young men with urine osmolality over 800&#160;mmol/kg under conditions of daily life, chronic hypertonicity and mild (&lt;2%) TBW deficit appear associated with metabolic and physiologic adaptations that result in water retention in response to hypotonic challenge <xref rid="b0155" ref-type="bibr">[31]</xref>. Four weeks of sustained higher intake of drinking water (&gt;+1L/d) is associated with a mean (SE) decrease in HOMA-IR of 2.2 (0.2) to 1.7 (0.1), a mean (SE) increase in plasma aldosterone from 111 (17) pg/ml to 143 (19) pg/ml and an average (SE) increase in body weight of +1.8 (0.5) percent <xref rid="b0160" ref-type="bibr">[32]</xref>, <xref rid="b0155" ref-type="bibr">[31]</xref>. While significant change in body weight is not detected from one week to the next, the cumulative change over 4&#160;weeks is statistically significant and correlated with increases in serum sodium and a muted change in water turnover <xref rid="b0155" ref-type="bibr">[31]</xref>.</p></sec><sec id="s0060"><title>Adaptation to chronic <underline>hyper</underline>tonicity presets for overreaction to <underline>hypo</underline>tonic challenge</title><p id="p0115">Cells that have adapted to hypertonic conditions are vulnerable to over-swell or lyse if exposed to hypotonic conditions. The higher intracellular osmolyte concentrations draw water in by osmosis. The phenomenon is well-established as a complication of hyperglycemic hypertonic dehydration in diabetic patients <xref rid="b0225" ref-type="bibr">[45]</xref>, source of systematic error in the hematology literature <xref rid="b0225" ref-type="bibr">[45]</xref>, cause of neuronal excitability <xref rid="b0230" ref-type="bibr">[46]</xref>, and hyponatremia associated brain damage <xref rid="b0235" ref-type="bibr">[47]</xref>. To protect against lysis, cells adapted to hypertonic conditions release more osmolytes given acute hypotonic challenge, compared to cells maintained in isotonic conditions or cells exposed to repeated hypotonic challenge <xref rid="b0240" ref-type="bibr">[48]</xref>.</p><p id="p0120">In healthy young men with usual total water intake below 2L/d and urine osmolality above 800&#160;mmol/kg, an acute bolus of 750&#160;ml drinking water reduces urine osmolality by over 700&#160;mmol/kg within 60&#160;min. After 4&#160;weeks of total water intake above 3L/d, the corresponding decrease in urine osmolality induced by an acute 750&#160;ml bolus is approximately halved <xref rid="b0160" ref-type="bibr">[32]</xref>, <xref rid="b0155" ref-type="bibr">[31]</xref>.</p></sec></sec><sec id="s0065"><title>Chronic suboptimal hydration may increase risk of COVID-19 infection</title><p id="p0125">Hypertonicity may increase risk of COVID-19 infection by reducing aldosterone <xref rid="b0175" ref-type="bibr">[35]</xref>, <xref rid="b0200" ref-type="bibr">[40]</xref>, <xref rid="b0205" ref-type="bibr">[41]</xref>, <xref rid="b0210" ref-type="bibr">[42]</xref>, <xref rid="b0215" ref-type="bibr">[43]</xref>, and/or increasing insulin resistance <xref rid="b0070" ref-type="bibr">[14]</xref>, <xref rid="b0220" ref-type="bibr">[44]</xref>, <xref rid="b0245" ref-type="bibr">[49]</xref>, which increase ACE2 receptors. The balance of ACE and ACE2 receptors regulates the RAAS. While ACE converts Ang I to Ang II, which has vasoconstricting effects, ACE2 converts Ang II to Ang-1&#8211;9 and Ang-1&#8211;7, which have opposite, vasodilating and anti-inflammatory, effects. ACE2 abundance is inversely related with aldosterone <xref rid="b0250" ref-type="bibr">[50]</xref>. Hypoaldosteronism is known to interrelate with diabetes and renal insufficiency for persons ages 50&#8211;70&#160;years <xref rid="b0255" ref-type="bibr">[51]</xref>. In rodent models ACE2 expression is increased by diabetes and decreased by insulin administration <xref rid="b0260" ref-type="bibr">[52]</xref>, <xref rid="b0265" ref-type="bibr">[53]</xref>. Diabetes is hypothesized to increase risk of COVID-19 infection by increasing ACE2 receptors <xref rid="b0270" ref-type="bibr">[54]</xref>.</p><p id="p0130">Chiusano et al. <xref rid="b0275" ref-type="bibr">[55]</xref> propose a model for describing mechanisms involved in COVID-19 infection that implicates ACE2 receptors, in conjunction with aldosterone and conditions that predispose to ARDS and poor disease outcome. ACE2 receptors are expressed by lung epithelial cells <xref rid="b0170" ref-type="bibr">[34]</xref>. The spike proteins of SARS-CoV bind to ACE2 receptors <xref rid="b0280" ref-type="bibr">[56]</xref>, <xref rid="b0170" ref-type="bibr">[34]</xref>, <xref rid="b0275" ref-type="bibr">[55]</xref>. Antibodies that bind ACE2 block SARS-CoV infection <xref rid="b0170" ref-type="bibr">[34]</xref>. &#8220;ACE2 has recently been identified as the SARS-CoV-2 receptor, the infective agent responsible for COVID-19, providing a critical link between immunity, inflammation, ACE2, and cardiovascular disease <xref rid="b0285" ref-type="bibr">[57]</xref>.&#8221; &#8220;We know that SARS-COV-2 is bound to ACE2 which serves as a portal of entry of the SARS-COV2 virus into cells&#8212;just as it was for the SARS and probably the MERS viruses. Theoretically, anything with increased ACE2 levels could make patients more susceptible to infection with coronavirus, and make their cases more severe <xref rid="b0290" ref-type="bibr">[58]</xref>.&#8221; &#8220;It is becoming evident that the RAAS system is involved in HCoV infections and presumably of high importance for their pathogenicity <xref rid="b0170" ref-type="bibr">[34]</xref>.&#8221; &#8220;Attention should&#8230; focus on monitoring COVID19 propensities for the &#8230;diseases or treatments that trigger ACE2 increase <xref rid="b0275" ref-type="bibr">[55]</xref>.&#8221;</p></sec><sec id="s0070"><title>Infection creates a hypotonic challenge</title><p id="p0135">During infection, monocytes and macrophages secrete cytokines, including tumor necrosis factor-alpha (TNF-alpha), interleukin-1beta (IL1B) and interleukin-6 (IL6), into the circulation <xref rid="b0295" ref-type="bibr">[59]</xref>. Increased plasma TNF-alpha, IL1B and IL6 stimulate secretion of corticotrophin-releasing hormone, adrenocorticotropic hormone, vasopressin and oxytocin <xref rid="b0300" ref-type="bibr">[60]</xref>, <xref rid="b0305" ref-type="bibr">[61]</xref>, which trigger antidiuresis and increase risk of hyponatremia <xref rid="b0295" ref-type="bibr">[59]</xref>.</p></sec><sec id="s0075"><title>Suboptimal hydration promotes an immune response like that described as a &#8216;cytokine storm&#8217;</title><p id="p0140">Preliminary data on COVID-19 and similarities between SARS-COV2 and other betacoronaviruses such as Severe Acute Respiratory Syndrome (SARS)-CoV or Middle East Respiratory Syndrome (MERS)-CoV suggest a 2-step pattern of activation of the immune system <xref rid="b0310" ref-type="bibr">[62]</xref>. During the type 1 IFN mediated initial step, in lung epithelial cells and macrophages, cascades of molecular events, via transcription factor nuclear factor &#954;B (NF-&#954;B) and IRF3/7, result in the production of cytokines such as IL1, IL6, or TNF-alpha. In some cases, the virus escapes the initial step, causing extra tissue damage and antibody response, which escalate subsequent immune response to the level of vicious cycle called cytokine storm <xref rid="b0310" ref-type="bibr">[62]</xref>; Additional, blood-derived macrophages/monocytes are attracted, activated and lead to uncontrolled, secondary innate and adaptive (T cell mediated) responses <xref rid="b0310" ref-type="bibr">[62]</xref>
<bold>.</bold>
</p><p id="p0145">Chronic hypertonicity in the weeks before infection could conceivably play a role in suppressing the initial immune response to COVID-19 by lung epithelial cells. In vitro, treatment of primary human small airway epithelial cells with hypertonic saline suppresses neutrophil, monocyte, and natural killer and T cell chemoattractants, as well as the pro-inflammatory cytokines IL32, IL6 and LIF <xref rid="b0130" ref-type="bibr">[26]</xref>. Adaptation to chronic hypertonicity before infection may delay the arrival of neutrophils, monocytes, natural killer and T cells in the early stage of infection, allowing time for the COVID-19 virus to replicate and infect more cells.</p><p id="p0150">Hypertonicity is described as a &#8220;danger signal&#8221; that boosts the immune system to ward off infection without need for de novo production of mediators <xref rid="b0315" ref-type="bibr">[63]</xref>. Hypertonicity may amplify neutrophil, monocyte, macrophage, and T cell response. Under the controlled environmental conditions of an enclosed spaceflight simulation center, compared to a lower salt diet of 6&#160;g/d, a high salt diet of 12&#160;g/d for 50 +/- 10&#160;days is associated with a marked increase in the number of monocytes and &#8220;potential risk of excessive immune response when infection occurs&#8221; in healthy young men <xref rid="b0320" ref-type="bibr">[64]</xref>. In a randomized, double-blind crossover study involving asthmatic patients, high salt diet for two weeks significantly increased post-exercise-induced sputum neutrophil and eosinophil differential cell counts and induced sputum supernatant concentration of eosinophil cationic protein, IL1beta, IL8, leukotriene (LT) C(4)-E(4), LTB(4), and prostaglandin D(2) compared to low salt diet <xref rid="b0325" ref-type="bibr">[65]</xref>. Adaptation to long-term or chronic hypertonicity may be required to magnify the immune response, as acute infusion of hypertonic saline does not significantly change the number of monocytes in young women <xref rid="b0330" ref-type="bibr">[66]</xref>. Effects of hypertonicity on immunity depend on the extent and duration of the hypertonic state <xref rid="b0335" ref-type="bibr">[67]</xref>.</p><p id="p0155">Effects of hypertonicity on neutrophils, T cells and macrophages in vitro and in animal models have been reviewed by K&#248;lsen-Petersen <xref rid="b0335" ref-type="bibr">[67]</xref>. Chronic hypertonicity impacts immune responses via signal transduction cascades that involve NF-&#954;B, p38 MAPK and NFAT5. NFAT5 coordinates expression of osmolytes <xref rid="b0165" ref-type="bibr">[33]</xref> and augments the effect of NF-&#954;B on critical aspects of the innate and adaptive immune responses <xref rid="b0340" ref-type="bibr">[68]</xref>.</p><p id="p0160">In vitro, hypertonicity stimulates the secretion of pro-inflammatory cytokines such as IL6 and TNF-alpha by monocytes and induces the stimulation of macrophages <xref rid="b0345" ref-type="bibr">[69]</xref>, <xref rid="b0350" ref-type="bibr">[70]</xref>, <xref rid="b0355" ref-type="bibr">[71]</xref>, <xref rid="b0360" ref-type="bibr">[72]</xref>. Monocytes that produce extra TNF-alpha are distinguished as an &#8220;inflammatory subset&#8221; with potent pro-inflammatory activity <xref rid="b0365" ref-type="bibr">[73]</xref>. TNF-alpha induces NF-&#954;B, thereby creating a feedback system that propagates and magnifies cytokine response <xref rid="b0340" ref-type="bibr">[68]</xref>.</p><p id="p0165">Increased extracellular osmolality also influences adaptive immunity. Hypertonic saline promotes T cell proliferation by increasing cAMP, which triggers a phosphorylation cascade that activates p38 MAPK in T cells, neutrophils, and monocytes <xref rid="b0370" ref-type="bibr">[74]</xref>, <xref rid="b0375" ref-type="bibr">[75]</xref>, which in turn increases IL2 production. In T cells, hypertonic conditions activate NFAT5, which upregulates TNF-alpha alongside increased expression of osmoprotective genes <xref rid="b0380" ref-type="bibr">[76]</xref>. High salt conditions promote the differentiation of CD4<sup>+</sup>&#160;helper T cells into IL17-producing CD4<sup>+</sup>&#160;helper T cells (TH17 cells), via p38 MAPK and NFAT5 <xref rid="b0385" ref-type="bibr">[77]</xref>, as well as serum/glucocorticoid-regulated kinase 1 (SGK1)-dependent signaling <xref rid="b0390" ref-type="bibr">[78]</xref>, <xref rid="b0395" ref-type="bibr">[79]</xref>. In vitro hypertonicity or in vivo high salt diet also impair the function of regulatory T cells (Tregs), that normally counteract the effects of Th17 cells, by increasing the SGK1-mediated production of interferon gamma and inducing a TH1 phenotype (TH1-like Tregs) <xref rid="b0400" ref-type="bibr">[80]</xref>. Th17 cells are involved in inflammation and drive autoimmune diseases in animal models <xref rid="b0395" ref-type="bibr">[79]</xref>. Induced activation of Th17 cells results in ARDS in mice <xref rid="b0405" ref-type="bibr">[81]</xref>.</p><p id="p0170">Regarding humoral immunity, hypertonicity participates in B cell activation and differentiation (Pax5 downregulation and CD138 upregulation) <xref rid="b0410" ref-type="bibr">[82]</xref>. In a secondary phase, it increases cell death and impairs plasmablast differentiation. Class switch to IgG1 is impaired, phosphorylation of p38 mitogen-activated kinase is inhibited and NFAT5 response is delayed.</p><p id="p0175">Hypovolemia, in the context of large loss of blood volume due to hemorrhage, is known to trigger the immune system and increase inflammation <xref rid="b0415" ref-type="bibr">[83]</xref> and neutrophil activation <xref rid="b0420" ref-type="bibr">[84]</xref>. Effects of hemorrhagic shock (hypovolemia) on immune response are similar enough to those of hyperosmotic stress to be considered equivalent <xref rid="b0425" ref-type="bibr">[85]</xref>.</p><p id="p0180">Finally, perhaps to balance or compensate for hypertonicity-induced increases in reactive oxygen species, and important when considering the context of infection-induced hypotonic challenge subsequent to adaptation to hypertonicity, chronic hypertonicity also increases intracellular glutathione, an antioxidant, via glutathione peroxidase (GPX) <xref rid="b0405" ref-type="bibr">[81]</xref>. Increased glutathione concentrations can restore redox balance and decrease the release of cytokines and chemokines from lung cells by decreasing NF-&#954;B activation <xref rid="b0430" ref-type="bibr">[86]</xref>, <xref rid="b0435" ref-type="bibr">[87]</xref>. The main function of endogenous intracellular glutathione is to gauge the innate immune response to infection <xref rid="b0440" ref-type="bibr">[88]</xref>.</p><sec id="s0080"><title><italic toggle="yes">Response to</italic><underline><italic toggle="yes">hypo</italic></underline><italic toggle="yes">tonicity after adaptation to</italic><underline><italic toggle="yes">hyper</italic></underline><italic toggle="yes">tonicity</italic></title><p id="p0185">Relative hypotonicity causes cell swelling by osmosis, which triggers cellular loss of organic osmolytes including amino acids, polyols and trimethylamines. Glutathione, a low molecular weight osmolyte and the most abundant intracellular antioxidant thiol, is depleted from cells in hyponatremia. The osmotically induced loss of intracellular glutathione makes cells more susceptible to oxidative injury <xref rid="b0445" ref-type="bibr">[89]</xref>. Glutathione production via glutathione peroxidase (GPX) is decreased by hypotonicity, delaying re-accumulation of intracellular glutathione concentrations after loss due to hypotonic swelling <xref rid="b0445" ref-type="bibr">[89]</xref>. An altered redox balance, excess generation vs. elimination of reactive oxygen species (ROS), is implicated in lung inflammation and ARDS <xref rid="b0450" ref-type="bibr">[90]</xref>, <xref rid="b0455" ref-type="bibr">[91]</xref>.</p><p id="p0190">
<italic toggle="yes">During lung injury</italic>, in the midst of the hypotonic challenge, hypertonic saline has an <underline>anti</underline>-inflammatory effect. During injury, hypertonicity promotes cell cycle arrest, and prevents ROS formation and mitochondria depolarization, mediated by p53-p21 signaling <xref rid="b0460" ref-type="bibr">[92]</xref>. This effect implies the converse, that relative hypotonicity during the inflammatory response decreases p53 gene regulation and cell cycle arrest and increases ROS formation and mitochondrial polarization. It is well established that the use of isotonic saline to restore blood volume and tissue perfusion after hemorrhagic shock results in edema formation, neutrophil activation and an inflammatory cascade <xref rid="b0405" ref-type="bibr">[81]</xref>. For individuals who are adapted to hypertonic conditions, it would not be surprising that restoration of hypertonic conditions with hypertonic saline has beneficial effects.</p><p id="p0195">Neutrophils are primary mediators of organ injury following trauma. The effect of hypertonicity on neutrophil activation depends on the timing of the hypertonicity <xref rid="b0335" ref-type="bibr">[67]</xref>. In vitro, it has been observed that if hypertonic saline is present before infection (lipopolysaccharide stimulation), then hypertonic solutions inhibit neutrophil activation in response to the infection <xref rid="b0425" ref-type="bibr">[85]</xref>, <xref rid="b0370" ref-type="bibr">[74]</xref>. After hypertonic conditioning, neutrophils have an exaggerated cytotoxic response in normotonic conditions. In vitro, the duration of hypertonic pretreatment modifies lung neutrophil responsiveness to infection under isotonic conditions <xref rid="b0465" ref-type="bibr">[93]</xref>.</p></sec></sec><sec id="s0085"><title>Suboptimal hydration increases risk of fluid leakage into the airway space</title><p id="p0200">Chronic hypertonicity and hypovolemia favor capillary leakage by increasing expression of VEGF, which stimulates lymphatic formation and endothelial nitric oxide synthase expression <xref rid="b0185" ref-type="bibr">[37]</xref>, <xref rid="b0190" ref-type="bibr">[38]</xref>. Increased expression of VEGF stimulates angiogenesis and can increase vascular permeability 20,000 times more potently than histamine <xref rid="b0470" ref-type="bibr">[94]</xref>, <xref rid="b0475" ref-type="bibr">[95]</xref>. It causes vasodilation, mediated by nitric oxide <xref rid="b0480" ref-type="bibr">[96]</xref>, <xref rid="b0485" ref-type="bibr">[97]</xref>.</p><p id="p0205">VEGF dysregulation is associated with ARDS <xref rid="b0490" ref-type="bibr">[98]</xref>, <xref rid="b0495" ref-type="bibr">[99]</xref>, <xref rid="b0500" ref-type="bibr">[100]</xref>. In mice, experimental overexpression of VEGF in alveolar epithelial cells is associated with capillary leakage and pulmonary edema <xref rid="b0495" ref-type="bibr">[99]</xref>, airway hyperresponsiveness, inflammation and mortality <xref rid="b0485" ref-type="bibr">[97]</xref>. Clinical studies report that ARDS patients have significantly higher plasma VEGF than normal controls and ventilated controls <xref rid="b0490" ref-type="bibr">[98]</xref>. Experimental data suggest that increases in plasma VEGF levels during infection determine ARDS risk. Following induced infection, mice that develop acute lung injury experience a significant increase in plasma VEGF levels by day 7 after infection, while mice that do not develop acute lung injury experience no significant change in VEGF levels <xref rid="b0500" ref-type="bibr">[100]</xref>.</p><p id="p0210">Both pre-infection hypertonicity and infection-induced hypotonicity might be expected to increase plasma VEGF, because both hypernatremia and hypotonicity-induced aldosterone may increase VEGF. Aldosterone increases VEGF-A mRNA and protein expression in a dose- and time-dependent manner in neutrophils via PI3 kinases, ERK1/2, and p38 MAPK <xref rid="b0745" ref-type="bibr">[148]</xref>. Angiogenesis is subject to U-shaped response curves [151].</p></sec><sec id="s0090"><title>Suboptimal hydration limits active transport of fluid out of the airway space</title><p id="p0215">Chronic hypertonicity and hypovolemia may limit active transport of fluid out of the lungs during COVID-19 infection by decreasing the expression of ENaC and Na<sup>+</sup>,K<sup>+</sup>
<sup>-</sup>ATPase. Fluid is normally removed from the alveolar space by active transport of sodium <xref rid="b0125" ref-type="bibr">[25]</xref> by Na<sup>+</sup> channels on the apical surface of the alveolar epithelium, and subsequently pumped out of the cell to the interstitium by Na<sup>+</sup>/K<sup>+</sup>-ATPase on the basal-lateral side [152]. The sodium potassium adenosine triphospatase (Na<sup>+</sup>/K<sup>+</sup>-ATPase) on the basolateral surface of alveolar type 1 epithelia creates a driving force that pulls Na<sup>+</sup> from the alveolar space through the epithelial sodium channel (ENaC) and other amiloride sensitive sodium channels on the apical surface [153].</p><p id="p0220">Active transport of sodium is impaired in ARDS <xref rid="b0505" ref-type="bibr">[101]</xref>. Dysregulation of the ion channels in alveolar epithelia cells causes pulmonary edema <xref rid="b0510" ref-type="bibr">[102]</xref>. Impaired ENaC predisposes to more severe lung injury <xref rid="b0515" ref-type="bibr">[103]</xref>, <xref rid="b0520" ref-type="bibr">[104]</xref>. A 50% reduction in both alpha1 and alpha 2 subunit protein expression of ENaC significantly decreases the maximal cAMP dependent fluid clearance <xref rid="b0525" ref-type="bibr">[105]</xref>. Recovery from pulmonary edema depends on active salt and water fluid transport from the distal air spaces. Increased ENaC and Na<sup>+</sup>/K<sup>+</sup>-ATPase activity can reduce the risk of acute lung injury <xref rid="b0530" ref-type="bibr">[106]</xref>, <xref rid="b0535" ref-type="bibr">[107]</xref>, <xref rid="b0540" ref-type="bibr">[108]</xref>.</p></sec><sec id="s0095"><title>Suboptimal hydration limits passive transport of fluid out of the airway space</title><p id="p0225">Chronic hypertonicity and hypovolemia may limit passive transport of fluid out of the lungs during COVID-19 infection by causing an exaggerated decrease in the membrane abundance of aquaporin 5 (AQP5) water channels in response to the hypotonic challenge created by the infection.</p><p id="p0230">AQP5 abundance is tightly regulated by osmolality and reduced in a stepwise fashion by extracellular hypotonicity <xref rid="b0545" ref-type="bibr">[109]</xref>. Cell responses to initial osmotic challenge and subsequent regulatory volume change require AQP5 <xref rid="b0550" ref-type="bibr">[110]</xref>. In individuals who are adapted to chronic hypertonicity before infection, the hypotonic conditions created during infection can be expected to represent a relatively more hypotonic challenge, resulting in an exaggerated reduction of AQP5 membrane abundance, compared to the response of individuals adapted to normotonic conditions before infection (See section on preliminary data and Appendix below). Downregulation of AQP5 decreases survival from sepsis induced lung injury <xref rid="b0555" ref-type="bibr">[111]</xref>.</p><p id="p0235">In rats, pulmonary expression of AQP1 and AQP5 is downregulated by hypovolemia, induced by acute hemorrhage, and lipopolysaccharide infection <xref rid="b0560" ref-type="bibr">[112]</xref>. The &#8220;decrease in both AQP1 and AQP5 may contribute to edema by essentially reducing the transcellular rate of removal of excess water, thereby effectively trapping water in the alveolar and interstitial spaces. These changes in AQP expressions either may represent a response to inflammation associated pulmonary edema or may be causal in the formation of pulmonary edema <xref rid="b0560" ref-type="bibr">[112]</xref>&#8221;.</p><p id="p0240">In mice, pulmonary inflammation induced by adenovirus infection and lipopolysaccharide significantly downregulates AQP5 expression <xref rid="b0565" ref-type="bibr">[113]</xref>, <xref rid="b0570" ref-type="bibr">[114]</xref>. Treatment of murine lung epithelial cells (MLE-12) with the proinflammatory cytokine TNF-alpha results in a concentration- and time-dependent decrease in AQP5 mRNA and protein expression <xref rid="b0575" ref-type="bibr">[115]</xref>. AQP5 expression is decreased 2-fold at the mRNA level and 10-fold at the protein level <xref rid="b0575" ref-type="bibr">[115]</xref>. The decreased AQP5 expression is sustained 7&#8211;14&#160;days after infection. The molecular pathway for the AQP5 downregulation involves TNF-alpha binding to a 55-kDa receptor (TNFR1) and/or to a 75-kDa receptor (TNFR2) <xref rid="b0575" ref-type="bibr">[115]</xref>, <xref rid="b0580" ref-type="bibr">[116]</xref>, alterations in gene expression via activation of multiple signal transduction pathways, including the MAP kinase family, ERK1/2, p38, and JNK <xref rid="b0585" ref-type="bibr">[117]</xref>, and NF-&#954;B <xref rid="b0590" ref-type="bibr">[118]</xref>, <xref rid="b0580" ref-type="bibr">[116]</xref>.</p></sec><sec id="s0100"><title>Intervention to address hydration status increases survival</title><p id="p0245">Experimental data indicate that intervention to improve hydration reduces ARDS mortality <xref rid="b0595" ref-type="bibr">[119]</xref>. Under conditions of hemorrhage and shock, hypertonic resuscitation solutions cause a high osmotic gradient that shifts water into the intravascular compartment from edematous endothelial cells, an immediate increase of systemic pressure and cardiac output with reduced peripheral vascular resistance, instantaneous increase of blood flow, resumption of organ function, increased urinary output, and increased survival rate <xref rid="b0595" ref-type="bibr">[119]</xref>. Hypertonic saline resuscitation inhibits LPS-induced TNF-alpha production, enhances IL10 release, and shifts the balance of pro- and counter-inflammatory cytokine production in favor of an anti-inflammatory response in alveolar macrophages <xref rid="b0600" ref-type="bibr">[120]</xref>. Nebulized hypertonic saline decreases lung inflammation, alveolar macrophage activation, and neutrophil recruitment into the lung <xref rid="b0605" ref-type="bibr">[121]</xref>. In ARDS, a negative cumulative fluid balance is associated with markedly increased survival <xref rid="b0035" ref-type="bibr">[7]</xref>, <xref rid="b0610" ref-type="bibr">[122]</xref>, <xref rid="b0615" ref-type="bibr">[123]</xref>.</p><p id="p0250">A large clinical network established through the National Heart, Lung and Blood Institute (NHLBI) developed fluid management guidelines that have improved outcomes for patients with ARDS <xref rid="b0620" ref-type="bibr">[124]</xref>. Consistent with a return to a pre-infection hypertonic state, hypertonic saline, and not isotonic saline, improves outcomes for ARDS patients <xref rid="b0615" ref-type="bibr">[123]</xref>.</p></sec></sec><sec id="s0105"><title>Alternative hypotheses</title><sec id="s0110"><title>Genetic predisposition</title><p id="p0255">Genetic susceptibility to COVID-19 cannot be ruled out as an explanation for increased COVID-19 mortality that is independent of hydration. A polymorphism that affects ACE activity is associated, for example, with ARDS mortality. ARDS patients with genotype leading to lower ACE activity have increased survival <xref rid="b0625" ref-type="bibr">[125]</xref>, <xref rid="b0630" ref-type="bibr">[126]</xref>. A common single nucleotide polymorphism (SNP; &#8722;1364A/C; rs3759129) in the AQP5 gene promoter, cytosine instead of adenosine at position &#8722;1364, is associated with decreased AQP5 expression <xref rid="b0635" ref-type="bibr">[127]</xref> and decreased survival from sepsis <xref rid="b0640" ref-type="bibr">[128]</xref>. A gain-of-function SGK1 polymorphism could cause metabolic syndrome on the one hand and augment the inflammatory response during COVID-19 induced ARDS on the other <xref rid="b0645" ref-type="bibr">[129]</xref>
</p></sec></sec><sec id="s0115"><title>Implications of the hypothesized mechanism</title><p id="p0260">The hypothesized mechanism(s) described above suggest opportunity for hydration-related strategies to limit COVID-19 mortality and motivate testable hypotheses regarding hydration screening to identify people at-risk, drinking water intervention to reduce COVID-19 infection and morbidity, and treatment protocol tailored to the pre-infection hydration condition.</p><sec id="s0120"><title>Potential for hydration screening to identify people at-risk</title><p id="p0265">Despite lack of a gold standard biomarker for hydration <xref rid="b0650" ref-type="bibr">[130]</xref> and controversy regarding chronic TBW deficit among non-acutely ill individuals under free-living conditions <xref rid="b0155" ref-type="bibr">[31]</xref>, biomarkers such as leukocyte SGK1 mRNA and saliva osmolality, at the cellular and physiological levels, respectively, may reflect chronic hypertonicity and/or TBW deficit and increased risk of COVID-19 infection, morbidity and/or mortality.</p><sec id="s0125"><title>Sgk1</title><p id="p0270">SGK1 is strongly upregulated by dehydration <xref rid="b0645" ref-type="bibr">[129]</xref> and contributes to the orchestration of inflammation <xref rid="b0655" ref-type="bibr">[131]</xref>. SGK1 stimulates IL23 <xref rid="b0390" ref-type="bibr">[78]</xref> to generate IL17-producing CD4<sup>+</sup>&#160;TH17 cells <xref rid="b0395" ref-type="bibr">[79]</xref>. TH17 cells, in turn, upregulate the pro-inflammatory cytokines GM-CSF, TNF-alpha and IL2 <xref rid="b0395" ref-type="bibr">[79]</xref>. Up-regulation of SGK1 theoretically predisposes to a severe course of lung infection.</p><p id="p0275">SGK1 participates in the orchestration of tissue fibrosis, by inactivating the ubiquitin ligase Nedd4L, which degrades TGF&#223;, a key stimulator of fibrosis <xref rid="b0660" ref-type="bibr">[132]</xref>. SGK1 activates NF&#954;B <xref rid="b0665" ref-type="bibr">[133]</xref>, a transcription factor fostering inflammation and fibrosis <xref rid="b0660" ref-type="bibr">[132]</xref>, <xref rid="b0670" ref-type="bibr">[134]</xref>, <xref rid="b0675" ref-type="bibr">[135]</xref>. Excessive SGK1 expression is observed in a wide variety of fibrosing diseases, including lung fibrosis <xref rid="b0660" ref-type="bibr">[132]</xref>, <xref rid="b0665" ref-type="bibr">[133]</xref>, <xref rid="b0680" ref-type="bibr">[136]</xref>, <xref rid="b0685" ref-type="bibr">[137]</xref>.</p><p id="p0285">SGK1 plays a pivotal role in platelet activation <xref rid="b0645" ref-type="bibr">[129]</xref>, which contributes to a severe course of COVID-19 infection <xref rid="b0690" ref-type="bibr">[138]</xref>
</p></sec><sec id="s0130"><title>Saliva osmolality</title><p id="p0290">Saliva osmolality has been proposed as a biomarker for isotonic dehydration <xref rid="b0695" ref-type="bibr">[139]</xref> and chronic TBW deficit <xref rid="b0155" ref-type="bibr">[31]</xref>. Unlike serum and urine osmolality, which are sensitive to acute change in TBW <xref rid="b0700" ref-type="bibr">[140]</xref>, <xref rid="b0705" ref-type="bibr">[141]</xref>, <xref rid="b0710" ref-type="bibr">[142]</xref>, saliva osmolality appears relatively more sensitive to longer-term hydration, over weeks, than serum or urine osmolality <xref rid="b0155" ref-type="bibr">[31]</xref> (See preliminary data and Appendix below). Saliva osmolality is regulated by aldosterone <xref rid="b0715" ref-type="bibr">[143]</xref>, <xref rid="b0720" ref-type="bibr">[144]</xref>.</p></sec></sec><sec id="s0135"><title>Potential for drinking water intervention</title><p id="p0295">As of August 2020, health authorities, including the WHO <xref rid="b0725" ref-type="bibr">[145]</xref> and CDC <xref rid="b0730" ref-type="bibr">[146]</xref>, advise the public to wash hands often with soap and water, avoid touching the face, avoid close contact with people by physical distancing and staying home, wear mouth covering around others, and regularly clean and disinfect. None of the recommended strategies explicitly work to correct chronic hypertonicity and/or hypovolemia. Prospective studies and randomized interventions might test if, in addition to sheltering in place, a sustained increase in drinking water <italic toggle="yes">over weeks</italic> lowers COVID-19 mortality to a greater extent than social distancing alone, by decreasing ACE2 receptors and improving immune response.</p><sec id="s0140"><title>Preliminary data regarding effects of drinking water intervention</title><p id="p0300">In healthy young men under conditions of daily life, sustaining an increase in total water intake from a baseline below 2L/d to above 3L/d for 4&#160;weeks by increasing intake of plain drinking water was associated with significant increases in plasma aldosterone <xref rid="b0155" ref-type="bibr">[31]</xref> and VEGF, and a smaller reduction in saliva AQP5 following acute hypotonic challenge (See Appendix). At baseline, 60&#160;min after an acute bolus of 750&#160;ml drinking water following overnight food and water restriction, the mean (SE) saliva AQP5 was 0.20 (0.09) ng/ml. After 4&#160;weeks of sustained higher water intake, the corresponding post-bolus mean (SE) saliva AQP5 was higher, 0.87 (0.43) ng/ml.</p><p id="p0305">The preliminary data also suggest that for individuals with usual total water intake below 2L/d and urine osmolality above 800&#160;ml/kg, saliva osmolality above 100&#160;mmol/kg (i.e. indication of TBW deficit in addition to hypertonicity) signals different response to drinking water intervention. After 4&#160;weeks of consuming &gt;+1L/d drinking water above baseline, individuals who initially have urine osmolality above 800&#160;mmol/kg and saliva osmolality above 100&#160;ml/kg show significantly greater increases in RBC glutathione peroxidase and RBC K:Na after a 750&#160;ml bolus of drinking water than individuals with initial saliva osmolality below 100&#160;mmol/kg (see Appendix).</p></sec></sec><sec id="s0145"><title>Potential to tailor treatment for COVID-19 to pre-infection hydration status</title><p id="p0310">Although &#8220;fluid management is important to consider as a measure to reduce pulmonary oedema <xref rid="b0065" ref-type="bibr">[13]</xref>&#8221;, treatment guidelines do not call attention to the <italic toggle="yes">pre-infection chronic hydration state</italic>. The guidelines focus on the acute hydration state during infection: &#8220;In the absence of shock, fluid conservative therapy is recommended to achieve a negative fluid balance of 0.5&#8211;1.0&#160;L per day. In the presence of shock, fluid balance might be achieved with renal replacement therapy, especially if there is associated acute kidney injury and oliguria <xref rid="b0065" ref-type="bibr">[13]</xref>.&#8221; &#8220;Therapeutically, hyponatremia during inflammation is challenging. However, it is important for physicians to beware of the predisposition to anti-diuresis in this context and adjust intravenous fluid therapy accordingly <xref rid="b0295" ref-type="bibr">[59]</xref>.&#8221;</p><p id="p0315">Treatment tailored to pre-infection hydration state is hampered by the fact that lab tests ordered when the patient presents to the clinic reflect status after infection. Recognized hydration lab tests such as urine osmolality, BUN:creatinine and serum osmolality are relatively insensitive to chronic hypertonicity over weeks <italic toggle="yes">before</italic> the infection. There is potential opportunity to add biomarkers of chronic hypertonicity, such as SGK1 and saliva osmolality, to clinical lab protocol.</p><p id="p0320">Wevers et al <xref rid="b0170" ref-type="bibr">[34]</xref> suggest that if the pathogenicity of coronavirus infections depends on dysregulation of the renin-aldosterone system, then &#8220;a therapy aimed at restoring the RAS equilibrium provides the opportunity to treat the symptoms of an infection. Especially in elderly patients, this treatment might be beneficial as the aged population is most vulnerable to deregulation of the RAS.&#8221;</p><p id="p0325">Chiusano et al <xref rid="b0275" ref-type="bibr">[55]</xref> hypothesize that the severity of COVID-19 infection is modulated by patient predisposition and capability to mount an appropriate immune response <italic toggle="yes">before</italic> infection.</p><p id="p0330">The success of hypertonic saline treatment may depend on preexisting dehydration <xref rid="b0405" ref-type="bibr">[81]</xref>, <xref rid="b0740" ref-type="bibr">[147]</xref>.</p></sec></sec><sec id="s0150"><title>Summary</title><p id="p0335">In sum, this paper hypothesizes that sub-optimal hydration in the weeks prior to exposure to COVID-19 increases risk of COVID-19 mortality via multiple possible pathways that favor fluid accumulation in the lungs. Evidence from in-vitro, animal, clinical and epidemiological studies suggest that chronic plasma hypertonicity, TBW deficit and/or hypovolemia may increase the likelihood of COVID-19 infection, pre-set the body for exaggerated immune response, increase tissue damage and leakage of fluid into the airway space, and/or decrease capacity for active and passive transport of fluid out of the airway space.</p><p id="p0340">Taken together, the evidence suggests that strategies to limit COVID-19 mortality may need to account for multiple determinants of water retention, fluid entry into and fluid removal out of the lungs, simultaneously. The mechanism(s) described above suggest testable hypotheses regarding screening to identify at-risk groups, public health recommendations to limit risk, and clinical treatment protocol. The pre-infection hydration condition is measurable by biomarkers and modifiable by drinking water. The United Nations imperative to have drinking water be available and accessible, worldwide <xref rid="b0745" ref-type="bibr">[148]</xref>, might be leveraged for COVID-19 risk reduction. Attention to hydration by clinicians, researchers and public health authorities has potential to block at least 5 pathways to COVID morbidity and holds promise to prevent death due to COVID-19.</p><p id="p0345">Grant support</p><p id="p0350">None.</p><p id="p0355">Conflict of interest</p><p id="p0360">In the past five years, J.D.S. and F.L. have provided consultant support to Danone Research.</p><p id="p0365">Authorship</p><p id="p0370">J.D.S conceived of this manuscript and drafted and finalized all sections. D.C. drafted the section regarding hypertonicity effects on immunity and reviewed the manuscript. P.K.R.A. and D.P. completed the SGK1 assays for the Adapt Study, drafted sections related to those results, and reviewed the manuscript. F.L. drafted the section regarding SGK1 and reviewed the manuscript.</p></sec></body><back><ref-list id="bi005"><title>References</title><ref id="b0005"><label>1</label><mixed-citation publication-type="other" id="h0005">Coronavirus may infect up to 70% of world&#8217;s population, expert warns &#8211; CBS News n.d. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.cbsnews.com/news/coronavirus-infection-outbreak-worldwide-virus-expert-warning-today-2020-03-02/" id="ir005">https://www.cbsnews.com/news/coronavirus-infection-outbreak-worldwide-virus-expert-warning-today-2020-03-02/</ext-link> (accessed April 28, 2020).</mixed-citation></ref><ref id="b0010"><label>2</label><mixed-citation publication-type="other" id="h0010">Trump&#8217;s plan to end coronavirus social distancing has sparked a major debate &#8211; Vox n.d. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.vox.com/coronavirus-covid19/2020/3/27/21193879/coronavirus-covid-19-social-distancing-economy-recession-depression" id="ir010">https://www.vox.com/coronavirus-covid19/2020/3/27/21193879/coronavirus-covid-19-social-distancing-economy-recession-depression</ext-link> (accessed April 28, 2020).</mixed-citation></ref><ref id="b0015"><label>3</label><mixed-citation publication-type="other" id="h0015">The Coronavirus Class Divide: Space and Privacy &#8211; The New York Times n.d. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.nytimes.com/2020/04/12/us/politics/coronavirus-poverty-privacy.html" id="ir015">https://www.nytimes.com/2020/04/12/us/politics/coronavirus-poverty-privacy.html</ext-link> (accessed May 8, 2020).</mixed-citation></ref><ref id="b0020"><label>4</label><mixed-citation publication-type="other" id="h0020">There are 300 Available Ventilators in San Diego County: Is That Enough? &#8211; NBC 7 San Diego n.d. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.nbcsandiego.com/news/investigations/there-are-300-available-ventilators-in-san-diego-county-is-that-enough/2291581/" id="ir020">https://www.nbcsandiego.com/news/investigations/there-are-300-available-ventilators-in-san-diego-county-is-that-enough/2291581/</ext-link> (accessed April 28, 2020).</mixed-citation></ref><ref id="b0025"><label>5</label><mixed-citation publication-type="other" id="h0025">What damage does COVID-19 do to your lungs? n.d. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.click2houston.com/features/2020/03/30/what-damage-does-covid-19-do-to-your-lungs/" id="ir025">https://www.click2houston.com/features/2020/03/30/what-damage-does-covid-19-do-to-your-lungs/</ext-link> (accessed April 28, 2020).</mixed-citation></ref><ref id="b0030"><label>6</label><mixed-citation publication-type="other" id="h0030">Here&#8217;s what coronavirus does to the body n.d. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.nationalgeographic.com/science/2020/02/here-is-what-coronavirus-does-to-the-body/" id="ir030">https://www.nationalgeographic.com/science/2020/02/here-is-what-coronavirus-does-to-the-body/</ext-link> (accessed April 28, 2020).</mixed-citation></ref><ref id="b0035"><label>7</label><element-citation publication-type="journal" id="h0035"><person-group person-group-type="author"><name name-style="western"><surname>Rahmel</surname><given-names>T.</given-names></name><name name-style="western"><surname>Nowak</surname><given-names>H.</given-names></name><name name-style="western"><surname>Rump</surname><given-names>K.</given-names></name><name name-style="western"><surname>Siffert</surname><given-names>W.</given-names></name><name name-style="western"><surname>Peters</surname><given-names>J.</given-names></name><name name-style="western"><surname>Adamzik</surname><given-names>M.</given-names></name></person-group><article-title>The aquaporin 5&#8211;1364A/C promoter polymorphism impacts on resolution of acute kidney injury in pneumonia evoked ARDS</article-title><source>PLoS ONE</source><volume>13</volume><year>2018</year><object-id pub-id-type="publisher-id">e0208582</object-id><pub-id pub-id-type="doi">10.1371/journal.pone.0208582</pub-id><pub-id pub-id-type="pmcid">PMC6281272</pub-id><pub-id pub-id-type="pmid">30517197</pub-id></element-citation></ref><ref id="b0040"><label>8</label><element-citation publication-type="journal" id="h0040"><person-group person-group-type="author"><name name-style="western"><surname>Bialek</surname><given-names>S.</given-names></name><name name-style="western"><surname>Boundy</surname><given-names>E.</given-names></name><name name-style="western"><surname>Bowen</surname><given-names>V.</given-names></name><name name-style="western"><surname>Chow</surname><given-names>N.</given-names></name><name name-style="western"><surname>Cohn</surname><given-names>A.</given-names></name><name name-style="western"><surname>Dowling</surname><given-names>N.</given-names></name></person-group><article-title>Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) &#8212; United States, February 12&#8211;March 16, 2020</article-title><source>MMWR Morb Mortal Wkly Rep</source><volume>69</volume><year>2020</year><fpage>343</fpage><lpage>346</lpage><pub-id pub-id-type="doi">10.15585/mmwr.mm6912e2</pub-id><pub-id pub-id-type="pmid">32214079</pub-id><pub-id pub-id-type="pmcid">PMC7725513</pub-id></element-citation></ref><ref id="b0045"><label>9</label><mixed-citation publication-type="other" id="h0045">Male vs female coronavirus deaths by country: Italy, China, Spain - Business Insider n.d. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.businessinsider.com/men-women-coronavirus-death-rates-by-country-worldwide-health-habits-2020-4" id="ir040">https://www.businessinsider.com/men-women-coronavirus-death-rates-by-country-worldwide-health-habits-2020-4</ext-link> (accessed May 10, 2020).</mixed-citation></ref><ref id="b0050"><label>10</label><mixed-citation publication-type="other" id="h0050">People Who Are at Higher Risk for Severe Illness|CDC n.d. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-at-higher-risk.html" id="ir045">https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-at-higher-risk.html</ext-link> (accessed April 28, 2020).</mixed-citation></ref><ref id="b0055"><label>11</label><element-citation publication-type="journal" id="h0055"><person-group person-group-type="author"><name name-style="western"><surname>Yancy</surname><given-names>C.W.</given-names></name></person-group><article-title>COVID-19 and African Americans</article-title><source>JAMA</source><volume>60611</volume><year>2020</year><pub-id pub-id-type="doi">10.1001/jama.2020.6548</pub-id><pub-id pub-id-type="pmid">32293639</pub-id></element-citation></ref><ref id="b0060"><label>12</label><mixed-citation publication-type="other" id="h0060">COVID-19 deaths analyzed by race and ethnicity &#8212; APM Research Lab n.d. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.apmresearchlab.org/covid/deaths-by-race" id="ir050">https://www.apmresearchlab.org/covid/deaths-by-race</ext-link> (accessed April 28, 2020).</mixed-citation></ref><ref id="b0065"><label>13</label><element-citation publication-type="journal" id="h0065"><person-group person-group-type="author"><name name-style="western"><surname>Matthay</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Aldrich</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Gotts</surname><given-names>J.E.</given-names></name></person-group><article-title>Treatment for severe acute respiratory distress syndrome from COVID-19</article-title><source>Lancet Respir Med</source><volume>2600</volume><year>2020</year><fpage>2019</fpage><lpage>2020</lpage><pub-id pub-id-type="doi">10.1016/S2213-2600(20)30127-2</pub-id><pub-id pub-id-type="pmcid">PMC7118607</pub-id><pub-id pub-id-type="pmid">32203709</pub-id></element-citation></ref><ref id="b0070"><label>14</label><element-citation publication-type="journal" id="h0070"><person-group person-group-type="author"><name name-style="western"><surname>Lang</surname><given-names>F.</given-names></name><name name-style="western"><surname>Busch</surname><given-names>G.L.</given-names></name><name name-style="western"><surname>Ritter</surname><given-names>M.</given-names></name><name name-style="western"><surname>V&#246;lkl</surname><given-names>H.</given-names></name><name name-style="western"><surname>Waldegger</surname><given-names>S.</given-names></name><name name-style="western"><surname>Gulbins</surname><given-names>E.</given-names></name></person-group><article-title>Functional significance of cell volume regulatory mechanisms</article-title><source>Physiol Rev</source><volume>78</volume><year>1998</year><fpage>247</fpage><lpage>306</lpage><pub-id pub-id-type="doi">10.1152/physrev.1998.78.1.247</pub-id><pub-id pub-id-type="pmid">9457175</pub-id></element-citation></ref><ref id="b0075"><label>15</label><element-citation publication-type="journal" id="h0075"><person-group person-group-type="author"><name name-style="western"><surname>Staub</surname><given-names>N.C.</given-names></name></person-group><article-title>Pulmonary edema</article-title><source>Physiol Rev</source><volume>54</volume><year>1974</year><fpage>678</fpage><lpage>811</lpage><pub-id pub-id-type="doi">10.1152/physrev.1974.54.3.678</pub-id><pub-id pub-id-type="pmid">4601625</pub-id></element-citation></ref><ref id="b0080"><label>16</label><element-citation publication-type="journal" id="h0080"><person-group person-group-type="author"><name name-style="western"><surname>Berthiaume</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Matthay</surname><given-names>M.A.</given-names></name></person-group><article-title>Alveolar edema fluid clearance and acute lung injury</article-title><source>Respir Physiol Neurobiol</source><volume>159</volume><year>2007</year><fpage>350</fpage><lpage>359</lpage><pub-id pub-id-type="doi">10.1016/j.resp.2007.05.010</pub-id><pub-id pub-id-type="pmid">17604701</pub-id><pub-id pub-id-type="pmcid">PMC2682357</pub-id></element-citation></ref><ref id="b0085"><label>17</label><element-citation publication-type="journal" id="h0085"><person-group person-group-type="author"><name name-style="western"><surname>Stookey</surname><given-names>J.D.</given-names></name></person-group><article-title>High prevalence of plasma hypertonicity among community-dwelling older adults: Results from NHANES III</article-title><source>J Am Diet Assoc</source><volume>105</volume><year>2005</year><fpage>1231</fpage><lpage>1239</lpage><pub-id pub-id-type="doi">10.1016/j.jada.2005.05.003</pub-id><pub-id pub-id-type="pmid">16182639</pub-id></element-citation></ref><ref id="b0090"><label>18</label><element-citation publication-type="journal" id="h0090"><person-group person-group-type="author"><name name-style="western"><surname>Stookey</surname><given-names>J.D.</given-names></name><name name-style="western"><surname>Kavouras</surname><given-names>S.</given-names></name><name name-style="western"><surname>Suh</surname><given-names>H.</given-names></name><name name-style="western"><surname>Lang</surname><given-names>F.</given-names></name></person-group><article-title>Underhydration is associated with obesity, chronic diseases, and death within 3 to 6 years in the u.S. population aged 51&#8211;70 years</article-title><source>Nutrients</source><volume>12</volume><year>2020</year><pub-id pub-id-type="doi">10.3390/nu12040905</pub-id><pub-id pub-id-type="pmcid">PMC7230456</pub-id><pub-id pub-id-type="pmid">32224908</pub-id></element-citation></ref><ref id="b0095"><label>19</label><element-citation publication-type="journal" id="h0095"><person-group person-group-type="author"><name name-style="western"><surname>Cumming</surname><given-names>K.</given-names></name><name name-style="western"><surname>Hoyle</surname><given-names>G.E.</given-names></name><name name-style="western"><surname>Hutchison</surname><given-names>J.D.</given-names></name><name name-style="western"><surname>Soiza</surname><given-names>R.L.</given-names></name></person-group><article-title>Prevalence, incidence and etiology of hyponatremia in elderly patients with fragility fractures</article-title><source>PLoS ONE</source><volume>9</volume><year>2014</year><object-id pub-id-type="publisher-id">e88272</object-id><pub-id pub-id-type="doi">10.1371/journal.pone.0088272</pub-id><pub-id pub-id-type="pmcid">PMC3914945</pub-id><pub-id pub-id-type="pmid">24505459</pub-id></element-citation></ref><ref id="b0100"><label>20</label><element-citation publication-type="journal" id="h0100"><person-group person-group-type="author"><name name-style="western"><surname>Marra</surname><given-names>M.V.</given-names></name><name name-style="western"><surname>Simmons</surname><given-names>S.F.</given-names></name><name name-style="western"><surname>Shotwell</surname><given-names>M.S.</given-names></name><name name-style="western"><surname>Hudson</surname><given-names>A.</given-names></name><name name-style="western"><surname>Hollingsworth</surname><given-names>E.K.</given-names></name><name name-style="western"><surname>Long</surname><given-names>E.</given-names></name></person-group><article-title>Elevated serum osmolality and total water deficit indicate impaired hydration status in residents of long-term care facilities regardless of low or high body mass index</article-title><source>J Acad Nutr Diet</source><volume>116</volume><issue>828&#8211;836</issue><year>2016</year><object-id pub-id-type="publisher-id">e2</object-id><pub-id pub-id-type="doi">10.1016/j.jand.2015.12.011</pub-id><pub-id pub-id-type="pmcid">PMC4852282</pub-id><pub-id pub-id-type="pmid">27126154</pub-id></element-citation></ref><ref id="b0105"><label>21</label><element-citation publication-type="journal" id="h0105"><person-group person-group-type="author"><name name-style="western"><surname>Soltani</surname><given-names>S.</given-names></name><name name-style="western"><surname>Kolahdouz Mohammadi</surname><given-names>R.</given-names></name><name name-style="western"><surname>Shab-Bidar</surname><given-names>S.</given-names></name><name name-style="western"><surname>Vafa</surname><given-names>M.</given-names></name><name name-style="western"><surname>Salehi-Abargouei</surname><given-names>A.</given-names></name></person-group><article-title>Sodium status and the metabolic syndrome: a systematic review and meta-analysis of observational studies</article-title><source>Crit Rev Food Sci Nutr</source><volume>59</volume><year>2019</year><fpage>196</fpage><lpage>206</lpage><pub-id pub-id-type="doi">10.1080/10408398.2017.1363710</pub-id><pub-id pub-id-type="pmid">28846446</pub-id></element-citation></ref><ref id="b0110"><label>22</label><element-citation publication-type="journal" id="h0110"><person-group person-group-type="author"><name name-style="western"><surname>El Boustany</surname><given-names>R.</given-names></name></person-group><article-title>Vasopressin and diabetic kidney disease</article-title><source>Ann Nutr Metab</source><volume>72</volume><year>2018</year><fpage>17</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1159/000488124</pub-id><pub-id pub-id-type="pmid">29925069</pub-id></element-citation></ref><ref id="b0115"><label>23</label><mixed-citation publication-type="other" id="h0115">Acute Kidney Injury (Acute Renal Failure) &#8211; PubMed &#8211; NCBI n.d. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/%3fterm%3dAbhinav%2bGoyal%253B%2bParnaz%2bDaneshpajouhnejad%253B%2bMuhammad%2bF.%2bHashmi%253B%2bKhalid%2bBashir.%2bAcute%2bKidney%2bInjury%2b(Acute%2bRenal%2bFailure)" id="ir055">https://www.ncbi.nlm.nih.gov/pubmed/?term=Abhinav+Goyal%3B+Parnaz+Daneshpajouhnejad%3B+Muhammad+F.+Hashmi%3B+Khalid+Bashir.+Acute+Kidney+Injury+(Acute+Renal+Failure)</ext-link> (accessed April 29, 2020).</mixed-citation></ref><ref id="b0120"><label>24</label><element-citation publication-type="journal" id="h0120"><person-group person-group-type="author"><name name-style="western"><surname>Giesbrecht</surname><given-names>G.G.</given-names></name><name name-style="western"><surname>Younes</surname><given-names>M.</given-names></name></person-group><article-title>Exercise- and cold-induced asthma</article-title><source>Can J Appl Physiol</source><volume>20</volume><year>1995</year><fpage>300</fpage><lpage>314</lpage><pub-id pub-id-type="doi">10.1139/h95-023</pub-id><pub-id pub-id-type="pmid">8541793</pub-id></element-citation></ref><ref id="b0125"><label>25</label><element-citation publication-type="journal" id="h0125"><person-group person-group-type="author"><name name-style="western"><surname>John</surname><given-names>S.</given-names></name><name name-style="western"><surname>Thuluvath</surname><given-names>P.J.</given-names></name></person-group><article-title>Hyponatremia in cirrhosis: Pathophysiology and management</article-title><source>World J Gastroenterol</source><volume>21</volume><year>2015</year><fpage>3197</fpage><lpage>3205</lpage><pub-id pub-id-type="doi">10.3748/wjg.v21.i11.3197</pub-id><pub-id pub-id-type="pmid">25805925</pub-id><pub-id pub-id-type="pmcid">PMC4363748</pub-id></element-citation></ref><ref id="b0130"><label>26</label><element-citation publication-type="journal" id="h0130"><person-group person-group-type="author"><name name-style="western"><surname>Mitra</surname><given-names>S.</given-names></name><name name-style="western"><surname>Schiller</surname><given-names>D.</given-names></name><name name-style="western"><surname>Anderson</surname><given-names>C.</given-names></name><name name-style="western"><surname>Gamboni</surname><given-names>F.</given-names></name><name name-style="western"><surname>D&#8217;Alessandro</surname><given-names>A.</given-names></name><name name-style="western"><surname>Kelher</surname><given-names>M.</given-names></name></person-group><article-title>Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia</article-title><source>PLoS ONE</source><volume>12</volume><year>2017</year><fpage>1</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1371/journal.pone.0189536</pub-id><pub-id pub-id-type="pmcid">PMC5734749</pub-id><pub-id pub-id-type="pmid">29253007</pub-id></element-citation></ref><ref id="b0135"><label>27</label><element-citation publication-type="journal" id="h0135"><person-group person-group-type="author"><name name-style="western"><surname>Stookey</surname><given-names>J.D.</given-names></name><name name-style="western"><surname>Purser</surname><given-names>J.L.</given-names></name><name name-style="western"><surname>Pieper</surname><given-names>C.F.</given-names></name><name name-style="western"><surname>Cohen</surname><given-names>H.J.</given-names></name></person-group><article-title>Plasma hypertonicity: another marker of frailty?</article-title><source>J Am Geriatr Soc</source><volume>52</volume><year>2004</year><fpage>1313</fpage><lpage>1320</lpage><pub-id pub-id-type="doi">10.1111/j.1532-5415.2004.52361.x</pub-id><pub-id pub-id-type="pmid">15271119</pub-id></element-citation></ref><ref id="b0140"><label>28</label><element-citation publication-type="journal" id="h0140"><person-group person-group-type="author"><name name-style="western"><surname>McManus</surname><given-names>M.L.</given-names></name><name name-style="western"><surname>Churchwell</surname><given-names>K.B.</given-names></name><name name-style="western"><surname>Strange</surname><given-names>K.</given-names></name></person-group><article-title>Regulation of cell volume in health and disease</article-title><source>N Engl J Med</source><volume>333</volume><year>1995</year><fpage>1260</fpage><lpage>1266</lpage><pub-id pub-id-type="pmid">7566004</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1056/NEJM199511093331906</pub-id></element-citation></ref><ref id="b0145"><label>29</label><element-citation publication-type="journal" id="h0145"><person-group person-group-type="author"><name name-style="western"><surname>Danziger</surname><given-names>J.</given-names></name><name name-style="western"><surname>Zeidel</surname><given-names>M.L.</given-names></name></person-group><article-title>Osmotic homeostasis</article-title><source>Clin J Am Soc Nephrol</source><volume>10</volume><year>2015</year><fpage>852</fpage><lpage>862</lpage><pub-id pub-id-type="doi">10.2215/CJN.10741013</pub-id><pub-id pub-id-type="pmid">25078421</pub-id><pub-id pub-id-type="pmcid">PMC4422250</pub-id></element-citation></ref><ref id="b0150"><label>30</label><element-citation publication-type="journal" id="h0150"><person-group person-group-type="author"><name name-style="western"><surname>Yancey</surname><given-names>P.H.</given-names></name><name name-style="western"><surname>Clark</surname><given-names>M.E.</given-names></name><name name-style="western"><surname>Hand</surname><given-names>S.C.</given-names></name><name name-style="western"><surname>Bowlus</surname><given-names>R.D.</given-names></name><name name-style="western"><surname>Somero</surname><given-names>G.N.</given-names></name></person-group><article-title>Living with water stress: evolution of osmolyte systems</article-title><source>Science (80-)</source><volume>217</volume><year>1982</year><fpage>1214</fpage><lpage>1222</lpage><pub-id pub-id-type="doi">10.1126/science.7112124</pub-id><pub-id pub-id-type="pmid">7112124</pub-id></element-citation></ref><ref id="b0155"><label>31</label><element-citation publication-type="journal" id="h0155"><person-group person-group-type="author"><name name-style="western"><surname>Stookey</surname><given-names>J.D.</given-names></name><name name-style="western"><surname>Hamer</surname><given-names>J.</given-names></name><name name-style="western"><surname>Killilea</surname><given-names>D.W.</given-names></name></person-group><article-title>Change in hydration indices associated with an increase in total water intake of more than 0.5 l/day, sustained over 4 weeks, in healthy young men with initial total water intake below 2 L/day</article-title><source>Physiol Rep</source><volume>5</volume><year>2017</year><fpage>1</fpage><lpage>22</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.14814/phy2.13356</pub-id><pub-id pub-id-type="pmcid">PMC5704074</pub-id><pub-id pub-id-type="pmid">29150589</pub-id></element-citation></ref><ref id="b0160"><label>32</label><element-citation publication-type="journal" id="h0160"><person-group person-group-type="author"><name name-style="western"><surname>Stookey</surname><given-names>J.D.</given-names></name><name name-style="western"><surname>Klein</surname><given-names>A.</given-names></name><name name-style="western"><surname>Hamer</surname><given-names>J.</given-names></name><name name-style="western"><surname>Chi</surname><given-names>C.</given-names></name><name name-style="western"><surname>Higa</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ng</surname><given-names>V.</given-names></name></person-group><article-title>RBC deformability and amino acid concentrations after hypo-osmotic challenge may reflect chronic cell hydration status in healthy young men</article-title><source>Physiol Rep</source><volume>1</volume><year>2013</year><pub-id pub-id-type="doi">10.1002/phy2.117</pub-id><pub-id pub-id-type="pmcid">PMC3841048</pub-id><pub-id pub-id-type="pmid">24303184</pub-id></element-citation></ref><ref id="b0165"><label>33</label><element-citation publication-type="book" id="h0165"><person-group person-group-type="author"><name name-style="western"><surname>Maldonado</surname><given-names>K.A.</given-names></name><name name-style="western"><surname>Mohiuddin</surname><given-names>S.S.</given-names></name></person-group><chapter-title>Biochemistry</chapter-title><year>2019</year><publisher-name>StatPearls Publishing</publisher-name><publisher-loc>Hypertonicity</publisher-loc><pub-id pub-id-type="pmid">31082139</pub-id></element-citation></ref><ref id="b0170"><label>34</label><element-citation publication-type="journal" id="h0170"><person-group person-group-type="author"><name name-style="western"><surname>Wevers</surname><given-names>B.A.</given-names></name><name name-style="western"><surname>Van Der Hoek</surname><given-names>L.</given-names></name></person-group><article-title>Renin-angiotensin system in human coronavirus pathogenesis</article-title><source>Future Virol</source><volume>5</volume><year>2010</year><fpage>145</fpage><lpage>161</lpage><pub-id pub-id-type="doi">10.2217/fvl.10.4</pub-id><pub-id pub-id-type="pmid">32201502</pub-id><pub-id pub-id-type="pmcid">PMC7079966</pub-id></element-citation></ref><ref id="b0175"><label>35</label><element-citation publication-type="journal" id="h0175"><person-group person-group-type="author"><name name-style="western"><surname>Carillo</surname><given-names>B.A.</given-names></name><name name-style="western"><surname>Beutel</surname><given-names>A.</given-names></name><name name-style="western"><surname>Mirandola</surname><given-names>D.A.</given-names></name><name name-style="western"><surname>Vidonho</surname><given-names>A.F.</given-names></name><name name-style="western"><surname>Furukawa</surname><given-names>L.N.S.</given-names></name><name name-style="western"><surname>Casarini</surname><given-names>D.</given-names></name></person-group><article-title>Differential sympathetic and angiotensinergic responses in rats submitted to low- or high-salt diet</article-title><source>Regul Pept</source><volume>140</volume><year>2007</year><fpage>5</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1016/j.regpep.2006.11.007</pub-id><pub-id pub-id-type="pmid">17196676</pub-id></element-citation></ref><ref id="b0180"><label>36</label><element-citation publication-type="journal" id="h0180"><person-group person-group-type="author"><name name-style="western"><surname>Viengchareun</surname><given-names>S.</given-names></name><name name-style="western"><surname>Kamenicky</surname><given-names>P.</given-names></name><name name-style="western"><surname>Teixeira</surname><given-names>M.</given-names></name><name name-style="western"><surname>Butlen</surname><given-names>D.</given-names></name><name name-style="western"><surname>Meduri</surname><given-names>G.</given-names></name><name name-style="western"><surname>Blanchard-Gutton</surname><given-names>N.</given-names></name></person-group><article-title>Osmotic stress regulates mineralocorticoid receptor expression in a novel aldosterone-sensitive cortical collecting duct cell line</article-title><source>Mol Endocrinol</source><volume>23</volume><year>2009</year><fpage>1948</fpage><lpage>1962</lpage><pub-id pub-id-type="doi">10.1210/me.2009-0095</pub-id><pub-id pub-id-type="pmid">19846540</pub-id><pub-id pub-id-type="pmcid">PMC2921568</pub-id></element-citation></ref><ref id="b0185"><label>37</label><element-citation publication-type="journal" id="h0185"><person-group person-group-type="author"><name name-style="western"><surname>Titze</surname><given-names>J.</given-names></name><name name-style="western"><surname>MacHnik</surname><given-names>A.</given-names></name></person-group><article-title>Sodium sensing in the interstitium and relationship to hypertension</article-title><source>Curr Opin Nephrol Hypertens</source><volume>19</volume><year>2010</year><fpage>385</fpage><lpage>392</lpage><pub-id pub-id-type="doi">10.1097/MNH.0b013e32833aeb3b</pub-id><pub-id pub-id-type="pmid">20571401</pub-id></element-citation></ref><ref id="b0190"><label>38</label><element-citation publication-type="journal" id="h0190"><person-group person-group-type="author"><name name-style="western"><surname>Ekerbicer</surname><given-names>N.</given-names></name><name name-style="western"><surname>Tarakci</surname><given-names>F.</given-names></name><name name-style="western"><surname>Barut</surname><given-names>T.</given-names></name><name name-style="western"><surname>Inan</surname><given-names>S.</given-names></name></person-group><article-title>Immunolocalization of VEGF, VEGFR-1 and VEGFR-2 in lung tissues after acute hemorrhage in rats</article-title><source>Acta Histochem</source><volume>110</volume><year>2008</year><fpage>285</fpage><lpage>293</lpage><pub-id pub-id-type="doi">10.1016/j.acthis.2007.10.010</pub-id><pub-id pub-id-type="pmid">18321563</pub-id></element-citation></ref><ref id="b0195"><label>39</label><element-citation publication-type="journal" id="h0195"><person-group person-group-type="author"><name name-style="western"><surname>Lang</surname><given-names>F.</given-names></name></person-group><article-title>Effect of cell hydration on metabolism</article-title><source>Nestle Nutr Inst Workshop Ser</source><volume>69</volume><year>2011</year><fpage>115</fpage><lpage>126</lpage><pub-id pub-id-type="doi">10.1159/000329290</pub-id><pub-id pub-id-type="pmid">22301839</pub-id></element-citation></ref><ref id="b0200"><label>40</label><element-citation publication-type="journal" id="h0200"><person-group person-group-type="author"><name name-style="western"><surname>Childers</surname><given-names>J.W.</given-names></name><name name-style="western"><surname>Schneider</surname><given-names>E.G.</given-names></name></person-group><article-title>Aldosterone and the enhanced natriuresis of hypertonic infusions in the dog</article-title><source>Am J Physiol &#8211; Ren Fluid Electrolyte Physiol</source><volume>11</volume><year>1982</year><pub-id pub-id-type="doi">10.1152/ajprenal.1982.242.1.f30</pub-id><pub-id pub-id-type="pmid">7058890</pub-id></element-citation></ref><ref id="b0205"><label>41</label><element-citation publication-type="journal" id="h0205"><person-group person-group-type="author"><name name-style="western"><surname>Merrill</surname><given-names>D.C.</given-names></name><name name-style="western"><surname>Ebert</surname><given-names>T.J.</given-names></name><name name-style="western"><surname>Skelton</surname><given-names>M.M.</given-names></name><name name-style="western"><surname>Cowley</surname><given-names>A.W.</given-names></name></person-group><article-title>Effect of plasma sodium on aldosterone secretion during angiotensin II stimulation in normal humans</article-title><source>Hypertension</source><volume>14</volume><year>1989</year><fpage>164</fpage><lpage>169</lpage><pub-id pub-id-type="doi">10.1161/01.HYP.14.2.164</pub-id><pub-id pub-id-type="pmid">2527200</pub-id></element-citation></ref><ref id="b0210"><label>42</label><element-citation publication-type="journal" id="h0210"><person-group person-group-type="author"><name name-style="western"><surname>Jensen</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Mose</surname><given-names>F.H.</given-names></name><name name-style="western"><surname>Bech</surname><given-names>J.N.</given-names></name><name name-style="western"><surname>Nielsen</surname><given-names>S.</given-names></name><name name-style="western"><surname>Pedersen</surname><given-names>E.B.</given-names></name></person-group><article-title>Effect of volume expansion with hypertonic- and isotonic saline and isotonic glucose on sodium and water transport in the principal cells in the kidney</article-title><source>BMC Nephrol</source><volume>14</volume><year>2013</year><pub-id pub-id-type="doi">10.1186/1471-2369-14-202</pub-id><pub-id pub-id-type="pmcid">PMC3849534</pub-id><pub-id pub-id-type="pmid">24067081</pub-id></element-citation></ref><ref id="b0215"><label>43</label><element-citation publication-type="journal" id="h0215"><person-group person-group-type="author"><name name-style="western"><surname>Van Regenmortel</surname><given-names>N.</given-names></name><name name-style="western"><surname>De Weerdt</surname><given-names>T.</given-names></name><name name-style="western"><surname>Van Craenenbroeck</surname><given-names>A.H.</given-names></name><name name-style="western"><surname>Roelant</surname><given-names>E.</given-names></name><name name-style="western"><surname>Verbrugghe</surname><given-names>W.</given-names></name><name name-style="western"><surname>Dams</surname><given-names>K.</given-names></name></person-group><article-title>Effect of isotonic versus hypotonic maintenance fluid therapy on urine output, fluid balance, and electrolyte homeostasis: a crossover study in fasting adult volunteers</article-title><source>Br J Anaesth</source><volume>118</volume><year>2017</year><fpage>892</fpage><lpage>900</lpage><pub-id pub-id-type="doi">10.1093/bja/aex118</pub-id><pub-id pub-id-type="pmid">28520883</pub-id><pub-id pub-id-type="pmcid">PMC5455256</pub-id></element-citation></ref><ref id="b0220"><label>44</label><element-citation publication-type="journal" id="h0220"><person-group person-group-type="author"><name name-style="western"><surname>Jansen</surname><given-names>L.T.</given-names></name><name name-style="western"><surname>Suh</surname><given-names>H.</given-names></name><name name-style="western"><surname>Adams</surname><given-names>J.D.</given-names></name><name name-style="western"><surname>Sprong</surname><given-names>C.A.</given-names></name><name name-style="western"><surname>Seal</surname><given-names>A.D.</given-names></name><name name-style="western"><surname>Scott</surname><given-names>D.M.</given-names></name></person-group><article-title>Osmotic stimulation of vasopressin acutely impairs glucose regulation: a counterbalanced, crossover trial</article-title><source>Am J Clin Nutr</source><volume>110</volume><year>2019</year><fpage>1344</fpage><lpage>1352</lpage><pub-id pub-id-type="pmid">31562496</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/ajcn/nqz236</pub-id></element-citation></ref><ref id="b0225"><label>45</label><element-citation publication-type="journal" id="h0225"><person-group person-group-type="author"><name name-style="western"><surname>Stookey</surname><given-names>J.D.</given-names></name><name name-style="western"><surname>Burg</surname><given-names>M.</given-names></name><name name-style="western"><surname>Sellmeyer</surname><given-names>D.E.</given-names></name><name name-style="western"><surname>Greenleaf</surname><given-names>J.E.</given-names></name><name name-style="western"><surname>Arieff</surname><given-names>A.</given-names></name><name name-style="western"><surname>Van Hove</surname><given-names>L.</given-names></name></person-group><article-title>A proposed method for assessing plasma hypertonicity in vivo</article-title><source>Eur J Clin Nutr</source><volume>61</volume><year>2007</year><fpage>143</fpage><lpage>146</lpage><pub-id pub-id-type="doi">10.1038/sj.ejcn.1602481</pub-id><pub-id pub-id-type="pmid">16855542</pub-id></element-citation></ref><ref id="b0230"><label>46</label><element-citation publication-type="journal" id="h0230"><person-group person-group-type="author"><name name-style="western"><surname>Sykov&#225;</surname><given-names>E.</given-names></name></person-group><article-title>Extrasynaptic volume transmission and diffusion parameters of the extracellular space</article-title><source>Neuroscience</source><volume>129</volume><year>2004</year><fpage>861</fpage><lpage>876</lpage><pub-id pub-id-type="doi">10.1016/j.neuroscience.2004.06.077</pub-id><pub-id pub-id-type="pmid">15561404</pub-id></element-citation></ref><ref id="b0235"><label>47</label><element-citation publication-type="journal" id="h0235"><person-group person-group-type="author"><name name-style="western"><surname>Fisher</surname><given-names>S.K.</given-names></name><name name-style="western"><surname>Cheema</surname><given-names>T.A.</given-names></name><name name-style="western"><surname>Foster</surname><given-names>D.J.</given-names></name><name name-style="western"><surname>Heacock</surname><given-names>A.M.</given-names></name></person-group><article-title>Volume-dependent osmolyte efflux from neural tissues: Regulation by G-protein-coupled receptors</article-title><source>J Neurochem</source><volume>106</volume><year>2008</year><fpage>1998</fpage><lpage>2014</lpage><pub-id pub-id-type="doi">10.1111/j.1471-4159.2008.05510.x</pub-id><pub-id pub-id-type="pmid">18518929</pub-id><pub-id pub-id-type="pmcid">PMC2574907</pub-id></element-citation></ref><ref id="b0240"><label>48</label><element-citation publication-type="journal" id="h0240"><person-group person-group-type="author"><name name-style="western"><surname>Ordaz</surname><given-names>B.</given-names></name><name name-style="western"><surname>Tuz</surname><given-names>K.</given-names></name><name name-style="western"><surname>Ochoa</surname><given-names>L.D.</given-names></name><name name-style="western"><surname>Lezama</surname><given-names>R.</given-names></name><name name-style="western"><surname>Pe&#241;a-Segura</surname><given-names>C.</given-names></name><name name-style="western"><surname>Franco</surname><given-names>R.</given-names></name></person-group><article-title>Osmolytes and mechanisms involved in regulatory volume decrease under conditions of sudden or gradual osmolarity decrease</article-title><source>Neurochem Res</source><volume>29</volume><year>2004</year><fpage>65</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1023/b:nere.0000010434.06311.18</pub-id><pub-id pub-id-type="pmid">14992264</pub-id></element-citation></ref><ref id="b0245"><label>49</label><element-citation publication-type="journal" id="h0245"><person-group person-group-type="author"><name name-style="western"><surname>Bratusch Marrain</surname><given-names>P.R.</given-names></name><name name-style="western"><surname>DeFronzo</surname><given-names>R.A.</given-names></name></person-group><article-title>Impairment of insulin-mediated glucose metabolism by hyperosmolality in man</article-title><source>Diabetes</source><volume>32</volume><year>1983</year><fpage>1028</fpage><lpage>1034</lpage><pub-id pub-id-type="doi">10.2337/diab.32.11.1028</pub-id><pub-id pub-id-type="pmid">6416909</pub-id></element-citation></ref><ref id="b0250"><label>50</label><element-citation publication-type="journal" id="h0250"><person-group person-group-type="author"><name name-style="western"><surname>Yamamuro</surname><given-names>M.</given-names></name><name name-style="western"><surname>Yoshimura</surname><given-names>M.</given-names></name><name name-style="western"><surname>Nakayama</surname><given-names>M.</given-names></name><name name-style="western"><surname>Abe</surname><given-names>K.</given-names></name><name name-style="western"><surname>Sumida</surname><given-names>H.</given-names></name><name name-style="western"><surname>Sugiyama</surname><given-names>S.</given-names></name></person-group><article-title>Aldosterone, but not angiotensin II, reduces angiotensin converting enzyme 2 gene expression levels in cultured neonatal rat cardiomyocytes</article-title><source>Circ J</source><volume>72</volume><year>2008</year><fpage>1346</fpage><lpage>1350</lpage><pub-id pub-id-type="doi">10.1253/circj.72.1346</pub-id><pub-id pub-id-type="pmid">18654024</pub-id></element-citation></ref><ref id="b0255"><label>51</label><element-citation publication-type="journal" id="h0255"><person-group person-group-type="author"><name name-style="western"><surname>Sousa</surname><given-names>A.G.P.</given-names></name><name name-style="western"><surname>Cabral</surname><given-names>J.V. de S.</given-names></name><name name-style="western"><surname>El-Feghaly</surname><given-names>W.B.</given-names></name><name name-style="western"><surname>de Sousa</surname><given-names>L.S.</given-names></name><name name-style="western"><surname>Nunes</surname><given-names>A.B.</given-names></name></person-group><article-title>Hyporeninemic hypoaldosteronism and diabetes mellitus: pathophysiology assumptions, clinical aspects and implications for management</article-title><source>World J Diabetes</source><volume>7</volume><year>2016</year><fpage>101</fpage><pub-id pub-id-type="doi">10.4239/wjd.v7.i5.101</pub-id><pub-id pub-id-type="pmid">26981183</pub-id><pub-id pub-id-type="pmcid">PMC4781902</pub-id></element-citation></ref><ref id="b0260"><label>52</label><element-citation publication-type="journal" id="h0260"><person-group person-group-type="author"><name name-style="western"><surname>Roca-Ho</surname><given-names>H.</given-names></name><name name-style="western"><surname>Riera</surname><given-names>M.</given-names></name><name name-style="western"><surname>Palau</surname><given-names>V.</given-names></name><name name-style="western"><surname>Pascual</surname><given-names>J.</given-names></name><name name-style="western"><surname>Soler</surname><given-names>M.J.</given-names></name></person-group><article-title>Characterization of ACE and ACE2 expression within different organs of the NOD mouse</article-title><source>Int J Mol Sci</source><volume>18</volume><year>2017</year><pub-id pub-id-type="doi">10.3390/ijms18030563</pub-id><pub-id pub-id-type="pmcid">PMC5372579</pub-id><pub-id pub-id-type="pmid">28273875</pub-id></element-citation></ref><ref id="b0265"><label>53</label><element-citation publication-type="journal" id="h0265"><person-group person-group-type="author"><name name-style="western"><surname>Wysocki</surname><given-names>J.</given-names></name><name name-style="western"><surname>Ye</surname><given-names>M.</given-names></name><name name-style="western"><surname>Soler</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Gurley</surname><given-names>S.B.</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>H.D.</given-names></name><name name-style="western"><surname>Bernstein</surname><given-names>K.E.</given-names></name></person-group><article-title>ACE and ACE2 activity in diabetic mice</article-title><source>Diabetes</source><volume>55</volume><year>2006</year><fpage>2132</fpage><lpage>2139</lpage><pub-id pub-id-type="doi">10.2337/db06-0033</pub-id><pub-id pub-id-type="pmid">16804085</pub-id></element-citation></ref><ref id="b0270"><label>54</label><element-citation publication-type="journal" id="h0270"><person-group person-group-type="author"><name name-style="western"><surname>Muniyappa</surname><given-names>R.</given-names></name><name name-style="western"><surname>Gubbi</surname><given-names>S.</given-names></name></person-group><article-title>COVID-19 pandemic, corona viruses, and diabetes mellitus</article-title><source>Am J Physiol Endocrinol Metab</source><volume>318</volume><year>2020</year><pub-id pub-id-type="doi">10.1152/ajpendo.00124.2020</pub-id><pub-id pub-id-type="pmcid">PMC7191633</pub-id><pub-id pub-id-type="pmid">32228322</pub-id></element-citation></ref><ref id="b0275"><label>55</label><mixed-citation publication-type="other" id="h0275">Chiusano ML. The modelling of COVID19 pathways sheds light on mechanisms, opportunities and on controversial interpretations of medical treatments. v2 2020.</mixed-citation></ref><ref id="b0280"><label>56</label><element-citation publication-type="journal" id="h0280"><person-group person-group-type="author"><name name-style="western"><surname>Cheng</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Luo</surname><given-names>R.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>K.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>M.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Dong</surname><given-names>L.</given-names></name></person-group><article-title>Kidney disease is associated with in-hospital death of patients with COVID-19</article-title><source>Kidney Int</source><volume>97</volume><year>2020</year><fpage>829</fpage><lpage>838</lpage><pub-id pub-id-type="doi">10.1016/j.kint.2020.03.005</pub-id><pub-id pub-id-type="pmid">32247631</pub-id><pub-id pub-id-type="pmcid">PMC7110296</pub-id></element-citation></ref><ref id="b0285"><label>57</label><element-citation publication-type="journal" id="h0285"><person-group person-group-type="author"><name name-style="western"><surname>Gheblawi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>K.</given-names></name><name name-style="western"><surname>Viveiros</surname><given-names>A.</given-names></name><name name-style="western"><surname>Nguyen</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Zhong</surname><given-names>J.-C.</given-names></name><name name-style="western"><surname>Turner</surname><given-names>A.J.</given-names></name></person-group><article-title>Angiotensin converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system</article-title><source>Circ Res</source><year>2020</year><pub-id pub-id-type="doi">10.1161/circresaha.120.317015</pub-id><pub-id pub-id-type="pmcid">PMC7188049</pub-id><pub-id pub-id-type="pmid">32264791</pub-id></element-citation></ref><ref id="b0290"><label>58</label><mixed-citation publication-type="other" id="h0290">Simon Murray M. ACE Inhibitors &amp; ARBs: Wading Into the Unknown of COVID-19; 2020.</mixed-citation></ref><ref id="b0295"><label>59</label><element-citation publication-type="journal" id="h0295"><person-group person-group-type="author"><name name-style="western"><surname>Swart</surname><given-names>R.M.</given-names></name><name name-style="western"><surname>Hoorn</surname><given-names>E.J.</given-names></name><name name-style="western"><surname>Betjes</surname><given-names>M.G.</given-names></name><name name-style="western"><surname>Zietse</surname><given-names>R.</given-names></name></person-group><article-title>Hyponatremia and inflammation: the emerging role of interleukin-6 in osmoregulation</article-title><source>Nephron &#8211; Physiol</source><volume>118</volume><year>2011</year><fpage>45</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1159/000322238</pub-id><pub-id pub-id-type="pmid">21196778</pub-id></element-citation></ref><ref id="b0300"><label>60</label><element-citation publication-type="journal" id="h0300"><person-group person-group-type="author"><name name-style="western"><surname>Melmed</surname><given-names>S.</given-names></name></person-group><article-title>Series Introduction: the immuno-neuroendocrine interface</article-title><source>J Clin Invest</source><volume>108</volume><year>2001</year><fpage>1563</fpage><lpage>1566</lpage><pub-id pub-id-type="doi">10.1172/jci14604</pub-id><pub-id pub-id-type="pmid">11733548</pub-id><pub-id pub-id-type="pmcid">PMC201000</pub-id></element-citation></ref><ref id="b0305"><label>61</label><element-citation publication-type="journal" id="h0305"><person-group person-group-type="author"><name name-style="western"><surname>Kasting</surname><given-names>N.W.</given-names></name><name name-style="western"><surname>Mazurek</surname><given-names>M.F.</given-names></name><name name-style="western"><surname>Martin</surname><given-names>J.B.</given-names></name></person-group><article-title>Endotoxin increases vasopressin release independently of known physiological stimuli</article-title><source>Am J Physiol &#8211; Endocrinol Metab</source><volume>11</volume><year>1985</year><pub-id pub-id-type="doi">10.1152/ajpendo.1985.248.4.e420</pub-id><pub-id pub-id-type="pmid">3885754</pub-id></element-citation></ref><ref id="b0310"><label>62</label><element-citation publication-type="journal" id="h0310"><person-group person-group-type="author"><name name-style="western"><surname>Felsenstein</surname><given-names>S.</given-names></name><name name-style="western"><surname>Herbert</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>McNamara</surname><given-names>P.S.</given-names></name><name name-style="western"><surname>Hedrich</surname><given-names>C.M.</given-names></name></person-group><article-title>COVID-19: Immunology and treatment options</article-title><source>Clin Immunol</source><volume>215</volume><year>2020</year><pub-id pub-id-type="doi">10.1016/j.clim.2020.108448</pub-id><pub-id pub-id-type="pmcid">PMC7185015</pub-id><pub-id pub-id-type="pmid">32353634</pub-id></element-citation></ref><ref id="b0315"><label>63</label><mixed-citation publication-type="other" id="h0315">Schatz V, Neubert P, Schr&#246;der A, Binger K, Gebhard M, M&#252;ller DN, et al. Elementary immunology&#160;: Na + as a regulator of immunity 2017:201&#8211;10. https://doi.org/10.1007/s00467-016-3349-x.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00467-016-3349-x</pub-id><pub-id pub-id-type="pmcid">PMC5203836</pub-id><pub-id pub-id-type="pmid">26921211</pub-id></mixed-citation></ref><ref id="b0320"><label>64</label><element-citation publication-type="journal" id="h0320"><person-group person-group-type="author"><name name-style="western"><surname>Yi</surname><given-names>B.</given-names></name><name name-style="western"><surname>Titze</surname><given-names>J.</given-names></name><name name-style="western"><surname>Rykova</surname><given-names>M.</given-names></name><name name-style="western"><surname>Feuerecker</surname><given-names>M.</given-names></name><name name-style="western"><surname>Vassilieva</surname><given-names>G.</given-names></name><name name-style="western"><surname>Nichiporuk</surname><given-names>I.</given-names></name></person-group><article-title>Effects of dietary salt levels on monocytic cells and immune responses in healthy human subjects: A longitudinal study</article-title><source>Transl Res</source><volume>166</volume><year>2015</year><fpage>103</fpage><lpage>110</lpage><pub-id pub-id-type="doi">10.1016/j.trsl.2014.11.007</pub-id><pub-id pub-id-type="pmid">25497276</pub-id><pub-id pub-id-type="pmcid">PMC5538905</pub-id></element-citation></ref><ref id="b0325"><label>65</label><element-citation publication-type="journal" id="h0325"><person-group person-group-type="author"><name name-style="western"><surname>Mickleborough</surname><given-names>T.D.</given-names></name><name name-style="western"><surname>Lindley</surname><given-names>M.R.</given-names></name><name name-style="western"><surname>Ray</surname><given-names>S.</given-names></name></person-group><article-title>Dietary salt, airway inflammation, and diffusion capacity in exercise-induced asthma</article-title><source>Med Sci Sports Exerc</source><volume>37</volume><year>2005</year><fpage>904</fpage><lpage>914</lpage><pub-id pub-id-type="doi">10.1249/01.mss.0000166949.11296.2b</pub-id><pub-id pub-id-type="pmid">15947713</pub-id></element-citation></ref><ref id="b0330"><label>66</label><element-citation publication-type="journal" id="h0330"><person-group person-group-type="author"><name name-style="western"><surname>Kolsen-Petersen</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Nielsen</surname><given-names>J.O.D.</given-names></name><name name-style="western"><surname>Bendtzen</surname><given-names>K.</given-names></name><name name-style="western"><surname>Tonnesen</surname><given-names>E.</given-names></name></person-group><article-title>Infusion of hypertonic saline (7.5% NaCl) causes minor immunological changes in normovolaemic women</article-title><source>Acta Anaesthesiol Scand</source><volume>48</volume><year>2004</year><fpage>224</fpage><lpage>233</lpage><pub-id pub-id-type="doi">10.1111/j.0001-5172.2004.00301.x</pub-id><pub-id pub-id-type="pmid">14995946</pub-id></element-citation></ref><ref id="b0335"><label>67</label><element-citation publication-type="journal" id="h0335"><person-group person-group-type="author"><name name-style="western"><surname>K&#248;lsen-Petersen</surname><given-names>J.A.</given-names></name></person-group><article-title>Immune effect of hypertonic saline: Fact or fiction?</article-title><source>Acta Anaesthesiol Scand</source><volume>48</volume><year>2004</year><fpage>667</fpage><lpage>678</lpage><pub-id pub-id-type="doi">10.1111/j.1399-6576.2004.00396.x</pub-id><pub-id pub-id-type="pmid">15196097</pub-id></element-citation></ref><ref id="b0340"><label>68</label><element-citation publication-type="journal" id="h0340"><person-group person-group-type="author"><name name-style="western"><surname>Hayden</surname><given-names>M.S.</given-names></name><name name-style="western"><surname>West</surname><given-names>A.P.</given-names></name><name name-style="western"><surname>Ghosh</surname><given-names>S.</given-names></name></person-group><article-title>NF-&#954;B and the immune response</article-title><source>Oncogene</source><volume>25</volume><year>2006</year><fpage>6758</fpage><lpage>6780</lpage><pub-id pub-id-type="doi">10.1038/sj.onc.1209943</pub-id><pub-id pub-id-type="pmid">17072327</pub-id></element-citation></ref><ref id="b0345"><label>69</label><element-citation publication-type="journal" id="h0345"><person-group person-group-type="author"><name name-style="western"><surname>Junger</surname><given-names>W.G.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>F.C.</given-names></name><name name-style="western"><surname>Loomis</surname><given-names>W.H.</given-names></name><name name-style="western"><surname>Hoyt</surname><given-names>D.B.</given-names></name></person-group><article-title>Hypertonic saline enhances cellular immune function</article-title><source>Circ Shock</source><volume>42</volume><year>1994</year><fpage>190</fpage><lpage>196</lpage><pub-id pub-id-type="pmid">8055665</pub-id></element-citation></ref><ref id="b0350"><label>70</label><element-citation publication-type="journal" id="h0350"><person-group person-group-type="author"><name name-style="western"><surname>Lang</surname><given-names>K.</given-names></name><name name-style="western"><surname>Fillon</surname><given-names>S.</given-names></name><name name-style="western"><surname>Schneider</surname><given-names>D.</given-names></name><name name-style="western"><surname>Rammensee</surname><given-names>H.G.</given-names></name><name name-style="western"><surname>Lang</surname><given-names>F.</given-names></name></person-group><article-title>Stimulation of TNF&#945; expression by hyperosmotic stress</article-title><source>Pflugers Arch Eur J Physiol</source><volume>443</volume><year>2002</year><fpage>798</fpage><lpage>803</lpage><pub-id pub-id-type="doi">10.1007/s00424-001-0768-7</pub-id><pub-id pub-id-type="pmid">11889578</pub-id></element-citation></ref><ref id="b0355"><label>71</label><element-citation publication-type="journal" id="h0355"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>W.C.</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>X.J.</given-names></name><name name-style="western"><surname>Du</surname><given-names>L.J.</given-names></name><name name-style="western"><surname>Sun</surname><given-names>J.Y.</given-names></name><name name-style="western"><surname>Shen</surname><given-names>Z.X.</given-names></name><name name-style="western"><surname>Shi</surname><given-names>C.</given-names></name></person-group><article-title>High salt primes a specific activation state of macrophages, M(Na)</article-title><source>Cell Res</source><volume>25</volume><year>2015</year><fpage>893</fpage><lpage>910</lpage><pub-id pub-id-type="doi">10.1038/cr.2015.87</pub-id><pub-id pub-id-type="pmid">26206316</pub-id><pub-id pub-id-type="pmcid">PMC4528058</pub-id></element-citation></ref><ref id="b0360"><label>72</label><element-citation publication-type="journal" id="h0360"><person-group person-group-type="author"><name name-style="western"><surname>Hucke</surname><given-names>S.</given-names></name><name name-style="western"><surname>Eschborn</surname><given-names>M.</given-names></name><name name-style="western"><surname>Liebmann</surname><given-names>M.</given-names></name><name name-style="western"><surname>Herold</surname><given-names>M.</given-names></name><name name-style="western"><surname>Freise</surname><given-names>N.</given-names></name><name name-style="western"><surname>Engbers</surname><given-names>A.</given-names></name></person-group><article-title>Sodium chloride promotes pro-inflammatory macrophage polarization thereby aggravating CNS autoimmunity</article-title><source>J Autoimmun</source><volume>67</volume><year>2016</year><fpage>90</fpage><lpage>101</lpage><pub-id pub-id-type="doi">10.1016/j.jaut.2015.11.001</pub-id><pub-id pub-id-type="pmid">26584738</pub-id></element-citation></ref><ref id="b0365"><label>73</label><element-citation publication-type="journal" id="h0365"><person-group person-group-type="author"><name name-style="western"><surname>Stansfield</surname><given-names>B.K.</given-names></name><name name-style="western"><surname>Ingram</surname><given-names>D.A.</given-names></name></person-group><article-title>Clinical significance of monocyte heterogeneity</article-title><source>Clin Transl Med</source><volume>4</volume><year>2015</year><pub-id pub-id-type="doi">10.1186/s40169-014-0040-3</pub-id><pub-id pub-id-type="pmcid">PMC4384980</pub-id><pub-id pub-id-type="pmid">25852821</pub-id></element-citation></ref><ref id="b0370"><label>74</label><element-citation publication-type="journal" id="h0370"><person-group person-group-type="author"><name name-style="western"><surname>Junger</surname><given-names>W.G.</given-names></name><name name-style="western"><surname>Hoyt</surname><given-names>D.B.</given-names></name><name name-style="western"><surname>Davis</surname><given-names>R.E.</given-names></name><name name-style="western"><surname>Herdon-Remelius</surname><given-names>C.</given-names></name><name name-style="western"><surname>Namiki</surname><given-names>S.</given-names></name><name name-style="western"><surname>Junger</surname><given-names>H.</given-names></name></person-group><article-title>Hypertonicity regulates the function of human neutrophils by modulating chemoattractant receptor signaling and activating mitogen-activated protein kinase p38</article-title><source>J Clin Invest</source><volume>101</volume><year>1998</year><fpage>2768</fpage><lpage>2779</lpage><pub-id pub-id-type="doi">10.1172/JCI1354</pub-id><pub-id pub-id-type="pmid">9637711</pub-id><pub-id pub-id-type="pmcid">PMC508868</pub-id></element-citation></ref><ref id="b0375"><label>75</label><element-citation publication-type="journal" id="h0375"><person-group person-group-type="author"><name name-style="western"><surname>Loomis</surname><given-names>W.H.</given-names></name><name name-style="western"><surname>Namiki</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ostrom</surname><given-names>R.S.</given-names></name><name name-style="western"><surname>Insel</surname><given-names>P.A.</given-names></name><name name-style="western"><surname>Junger</surname><given-names>W.G.</given-names></name></person-group><article-title>Hypertonic stress increases T cell interleukin-2 expression through a mechanism that involves ATP release, P2 receptor, and p38 MAPK activation</article-title><source>J Biol Chem</source><volume>278</volume><year>2003</year><fpage>4590</fpage><lpage>4596</lpage><pub-id pub-id-type="doi">10.1074/jbc.M207868200</pub-id><pub-id pub-id-type="pmid">12464620</pub-id></element-citation></ref><ref id="b0380"><label>76</label><element-citation publication-type="journal" id="h0380"><person-group person-group-type="author"><name name-style="western"><surname>L&#243;pez-Rodr&#237;guez</surname><given-names>C.</given-names></name><name name-style="western"><surname>Aramburu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Jin</surname><given-names>L.</given-names></name><name name-style="western"><surname>Rakeman</surname><given-names>A.S.</given-names></name><name name-style="western"><surname>Michino</surname><given-names>M.</given-names></name><name name-style="western"><surname>Rao</surname><given-names>A.</given-names></name></person-group><article-title>Bridging the NFAT and NF-&#954;B families: NFAT5 dimerization regulates cytokine gene transcription in response to osmotic stress</article-title><source>Immunity</source><volume>15</volume><year>2001</year><fpage>47</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1016/S1074-7613(01)00165-0</pub-id><pub-id pub-id-type="pmid">11485737</pub-id></element-citation></ref><ref id="b0385"><label>77</label><element-citation publication-type="journal" id="h0385"><person-group person-group-type="author"><name name-style="western"><surname>Alberdi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Iglesias</surname><given-names>M.</given-names></name><name name-style="western"><surname>Tejedor</surname><given-names>S.</given-names></name><name name-style="western"><surname>Merino</surname><given-names>R.</given-names></name><name name-style="western"><surname>L&#243;pez-Rodr&#237;guez</surname><given-names>C.</given-names></name><name name-style="western"><surname>Aramburu</surname><given-names>J.</given-names></name></person-group><article-title>Context-dependent regulation of Th17-associated genes and IFN&#947; expression by the transcription factor NFAT5</article-title><source>Immunol Cell Biol</source><volume>95</volume><year>2017</year><fpage>56</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1038/icb.2016.69</pub-id><pub-id pub-id-type="pmid">27479742</pub-id><pub-id pub-id-type="pmcid">PMC5215110</pub-id></element-citation></ref><ref id="b0390"><label>78</label><element-citation publication-type="journal" id="h0390"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>C.</given-names></name><name name-style="western"><surname>Yosef</surname><given-names>N.</given-names></name><name name-style="western"><surname>Thalhamer</surname><given-names>T.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>C.</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>S.</given-names></name><name name-style="western"><surname>Kishi</surname><given-names>Y.</given-names></name></person-group><article-title>Induction of pathogenic TH 17 cells by inducible salt-sensing kinase SGK1</article-title><source>Nature</source><volume>496</volume><year>2013</year><fpage>513</fpage><lpage>517</lpage><pub-id pub-id-type="doi">10.1038/nature11984</pub-id><pub-id pub-id-type="pmid">23467085</pub-id><pub-id pub-id-type="pmcid">PMC3637879</pub-id></element-citation></ref><ref id="b0395"><label>79</label><element-citation publication-type="journal" id="h0395"><person-group person-group-type="author"><name name-style="western"><surname>Kleinewietfeld</surname><given-names>M.</given-names></name><name name-style="western"><surname>Manzel</surname><given-names>A.</given-names></name><name name-style="western"><surname>Titze</surname><given-names>J.</given-names></name><name name-style="western"><surname>Kvakan</surname><given-names>H.</given-names></name><name name-style="western"><surname>Yosef</surname><given-names>N.</given-names></name><name name-style="western"><surname>Linker</surname><given-names>R.A.</given-names></name></person-group><article-title>Sodium chloride drives autoimmune disease by the induction of pathogenic TH 17 cells</article-title><source>Nature</source><volume>496</volume><year>2013</year><fpage>518</fpage><lpage>522</lpage><pub-id pub-id-type="doi">10.1038/nature11868</pub-id><pub-id pub-id-type="pmid">23467095</pub-id><pub-id pub-id-type="pmcid">PMC3746493</pub-id></element-citation></ref><ref id="b0400"><label>80</label><element-citation publication-type="journal" id="h0400"><person-group person-group-type="author"><name name-style="western"><surname>Hernandez</surname><given-names>A.L.</given-names></name><name name-style="western"><surname>Kitz</surname><given-names>A.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>C.</given-names></name><name name-style="western"><surname>Lowther</surname><given-names>D.E.</given-names></name><name name-style="western"><surname>Rodriguez</surname><given-names>D.M.</given-names></name><name name-style="western"><surname>Vudattu</surname><given-names>N.</given-names></name></person-group><article-title>Sodium chloride inhibits the suppressive function of FOXP3+ regulatory T cells</article-title><source>J Clin Invest</source><volume>125</volume><year>2015</year><fpage>4212</fpage><lpage>4222</lpage><pub-id pub-id-type="doi">10.1172/JCI81151</pub-id><pub-id pub-id-type="pmid">26524592</pub-id><pub-id pub-id-type="pmcid">PMC4639983</pub-id></element-citation></ref><ref id="b0405"><label>81</label><element-citation publication-type="journal" id="h0405"><person-group person-group-type="author"><name name-style="western"><surname>Shukla</surname><given-names>A.</given-names></name><name name-style="western"><surname>Hashiguchi</surname><given-names>N.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Coimbra</surname><given-names>R.</given-names></name><name name-style="western"><surname>Hoyt</surname><given-names>D.B.</given-names></name><name name-style="western"><surname>Junger</surname><given-names>W.G.</given-names></name></person-group><article-title>Review article</article-title><source>DNA Repair (Amst)</source><volume>21</volume><year>2004</year><fpage>391</fpage><lpage>400</lpage><pub-id pub-id-type="doi">10.1097/01.shk.0000125478.37219.48</pub-id></element-citation></ref><ref id="b0410"><label>82</label><element-citation publication-type="journal" id="h0410"><person-group person-group-type="author"><name name-style="western"><surname>Cvetkovic</surname><given-names>L.</given-names></name><name name-style="western"><surname>Perisic</surname><given-names>S.</given-names></name><name name-style="western"><surname>Titze</surname><given-names>J.</given-names></name><name name-style="western"><surname>J&#228;ck</surname><given-names>H.-M.</given-names></name><name name-style="western"><surname>Schuh</surname><given-names>W.</given-names></name></person-group><article-title>The impact of hyperosmolality on activation and differentiation of B lymphoid cells</article-title><source>Front Immunol</source><volume>10</volume><year>2019</year><fpage>828</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2019.00828</pub-id><pub-id pub-id-type="pmid">31057551</pub-id><pub-id pub-id-type="pmcid">PMC6482216</pub-id></element-citation></ref><ref id="b0415"><label>83</label><element-citation publication-type="journal" id="h0415"><person-group person-group-type="author"><name name-style="western"><surname>Sato</surname><given-names>H.</given-names></name><name name-style="western"><surname>Tanaka</surname><given-names>T.</given-names></name><name name-style="western"><surname>Kasai</surname><given-names>K.</given-names></name><name name-style="western"><surname>Kita</surname><given-names>T.</given-names></name><name name-style="western"><surname>Tanaka</surname><given-names>N.</given-names></name></person-group><article-title>Role of p38 mitogen-activated protein kinase on cardiac dysfunction after hemorrhagic shock in rats</article-title><source>Shock</source><volume>28</volume><year>2007</year><fpage>291</fpage><lpage>299</lpage><pub-id pub-id-type="doi">10.1097/SHK.0b013e3180326e3d</pub-id><pub-id pub-id-type="pmid">17545949</pub-id></element-citation></ref><ref id="b0420"><label>84</label><element-citation publication-type="journal" id="h0420"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>H.</given-names></name><name name-style="western"><surname>Alam</surname><given-names>H.B.</given-names></name><name name-style="western"><surname>Querol</surname><given-names>R.I.L.C.</given-names></name><name name-style="western"><surname>Rhee</surname><given-names>P.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Koustova</surname><given-names>E.</given-names></name></person-group><article-title>Identification of expression patterns associated with hemorrhage and resuscitation: integrated approach to data analysis</article-title><source>J Trauma -&#8211;Inj Infect Crit Care</source><volume>60</volume><year>2006</year><fpage>701</fpage><lpage>724</lpage><pub-id pub-id-type="doi">10.1097/01.ta.0000203699.91475.f6</pub-id><pub-id pub-id-type="pmid">16612289</pub-id></element-citation></ref><ref id="b0425"><label>85</label><element-citation publication-type="journal" id="h0425"><person-group person-group-type="author"><name name-style="western"><surname>Junger</surname><given-names>W.G.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>F.C.</given-names></name><name name-style="western"><surname>Loomis</surname><given-names>W.H.H.D.</given-names></name></person-group><article-title>Hypertonic saline enhances cellular immune function</article-title><source>Circ Shock</source><volume>42</volume><year>1994</year><fpage>190</fpage><lpage>196</lpage><pub-id pub-id-type="pmid">8055665</pub-id></element-citation></ref><ref id="b0430"><label>86</label><element-citation publication-type="journal" id="h0430"><person-group person-group-type="author"><name name-style="western"><surname>Antonicelli</surname><given-names>F.</given-names></name><name name-style="western"><surname>Parmentier</surname><given-names>M.</given-names></name><name name-style="western"><surname>Drost</surname><given-names>E.M.</given-names></name><name name-style="western"><surname>Hirani</surname><given-names>N.</given-names></name><name name-style="western"><surname>Rahman</surname><given-names>I.</given-names></name><name name-style="western"><surname>Donaldson</surname><given-names>K.</given-names></name></person-group><article-title>Nacystelyn inhibits oxidant-mediated interleukin-8 expression and NF-&#954;B nuclear binding in alveolar epithelial cells</article-title><source>Free Radic Biol Med</source><volume>32</volume><year>2002</year><fpage>492</fpage><lpage>502</lpage><pub-id pub-id-type="doi">10.1016/S0891-5849(01)00820-6</pub-id><pub-id pub-id-type="pmid">11958950</pub-id></element-citation></ref><ref id="b0435"><label>87</label><element-citation publication-type="journal" id="h0435"><person-group person-group-type="author"><name name-style="western"><surname>Aoki</surname><given-names>T.</given-names></name><name name-style="western"><surname>Suzuki</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Suzuki</surname><given-names>K.</given-names></name><name name-style="western"><surname>Miyata</surname><given-names>A.</given-names></name><name name-style="western"><surname>Oyamada</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Takasugi</surname><given-names>T.</given-names></name></person-group><article-title>Modulation of ICAM-1 expression by extracellular glutathione in hyperoxia-exposed human pulmonary artery endothelial cells</article-title><source>Am J Respir Cell Mol Biol</source><volume>15</volume><year>1996</year><fpage>319</fpage><lpage>327</lpage><pub-id pub-id-type="doi">10.1165/ajrcmb.15.3.8810635</pub-id><pub-id pub-id-type="pmid">8810635</pub-id></element-citation></ref><ref id="b0440"><label>88</label><element-citation publication-type="journal" id="h0440"><person-group person-group-type="author"><name name-style="western"><surname>Diotallevi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Checconi</surname><given-names>P.</given-names></name><name name-style="western"><surname>Palamara</surname><given-names>A.T.</given-names></name><name name-style="western"><surname>Celestino</surname><given-names>I.</given-names></name><name name-style="western"><surname>Coppo</surname><given-names>L.</given-names></name><name name-style="western"><surname>Holmgren</surname><given-names>A.</given-names></name></person-group><article-title>Glutathione fine-tunes the innate immune response toward antiviral pathways in a macrophage cell line independently of its antioxidant properties</article-title><source>Front Immunol</source><volume>8</volume><year>2017</year><pub-id pub-id-type="doi">10.3389/fimmu.2017.01239</pub-id><pub-id pub-id-type="pmcid">PMC5626850</pub-id><pub-id pub-id-type="pmid">29033950</pub-id></element-citation></ref><ref id="b0445"><label>89</label><element-citation publication-type="journal" id="h0445"><person-group person-group-type="author"><name name-style="western"><surname>Clark</surname><given-names>E.C.</given-names></name><name name-style="western"><surname>Thomas</surname><given-names>D.</given-names></name><name name-style="western"><surname>Baer</surname><given-names>J.</given-names></name><name name-style="western"><surname>Sterns</surname><given-names>R.H.</given-names></name></person-group><article-title>Depletion of glutathione from brain cells in hyponatremia</article-title><source>Kidney Int</source><volume>49</volume><year>1996</year><fpage>470</fpage><lpage>476</lpage><pub-id pub-id-type="doi">10.1038/ki.1996.66</pub-id><pub-id pub-id-type="pmid">8821831</pub-id></element-citation></ref><ref id="b0450"><label>90</label><element-citation publication-type="journal" id="h0450"><person-group person-group-type="author"><name name-style="western"><surname>Biswas</surname><given-names>S.K.</given-names></name><name name-style="western"><surname>Rahman</surname><given-names>I.</given-names></name></person-group><article-title>Environmental toxicity, redox signaling and lung inflammation: The role of glutathione</article-title><source>Mol Aspects Med</source><volume>30</volume><year>2009</year><fpage>60</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1016/j.mam.2008.07.001</pub-id><pub-id pub-id-type="pmid">18760298</pub-id><pub-id pub-id-type="pmcid">PMC2699458</pub-id></element-citation></ref><ref id="b0455"><label>91</label><element-citation publication-type="journal" id="h0455"><person-group person-group-type="author"><name name-style="western"><surname>Bunnell</surname><given-names>E.</given-names></name><name name-style="western"><surname>Pacht</surname><given-names>E.R.</given-names></name></person-group><article-title>Oxidized glutathione is increased in the alveolar fluid of patients with the adult respiratory distress syndrome</article-title><source>Am Rev Respir Dis</source><volume>148</volume><year>1993</year><fpage>1174</fpage><lpage>1178</lpage><pub-id pub-id-type="doi">10.1164/ajrccm/148.5.1174</pub-id><pub-id pub-id-type="pmid">8239150</pub-id></element-citation></ref><ref id="b0460"><label>92</label><element-citation publication-type="journal" id="h0460"><person-group person-group-type="author"><name name-style="western"><surname>Gamboni</surname><given-names>F.</given-names></name><name name-style="western"><surname>Anderson</surname><given-names>C.</given-names></name><name name-style="western"><surname>Mitra</surname><given-names>S.</given-names></name><name name-style="western"><surname>Reisz</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Nemkov</surname><given-names>T.</given-names></name><name name-style="western"><surname>Dzieciatkowska</surname><given-names>M.</given-names></name></person-group><article-title>Hypertonic saline primes activation of the p53&#8211;p21 signaling axis in human small airway epithelial cells that prevents inflammation induced by pro-inflammatory cytokines</article-title><source>J Proteome Res</source><volume>15</volume><year>2016</year><fpage>3813</fpage><lpage>3826</lpage><pub-id pub-id-type="doi">10.1021/acs.jproteome.6b00602</pub-id><pub-id pub-id-type="pmid">27529569</pub-id><pub-id pub-id-type="pmcid">PMC5811188</pub-id></element-citation></ref><ref id="b0465"><label>93</label><element-citation publication-type="journal" id="h0465"><person-group person-group-type="author"><name name-style="western"><surname>Rizoli</surname><given-names>S.B.</given-names></name><name name-style="western"><surname>Kapus</surname><given-names>A.</given-names></name><name name-style="western"><surname>Parodo</surname><given-names>J.</given-names></name><name name-style="western"><surname>Fan</surname><given-names>J.</given-names></name><name name-style="western"><surname>Rotstein</surname><given-names>O.D.</given-names></name></person-group><article-title>Hypertonic immunomodulation is reversible and accompanied by changes in CD11b expression</article-title><source>J Surg Res</source><volume>83</volume><year>1999</year><fpage>130</fpage><lpage>135</lpage><pub-id pub-id-type="doi">10.1006/jsre.1999.5581</pub-id><pub-id pub-id-type="pmid">10329106</pub-id></element-citation></ref><ref id="b0470"><label>94</label><element-citation publication-type="journal" id="h0470"><person-group person-group-type="author"><name name-style="western"><surname>Leung</surname><given-names>D.W.</given-names></name><name name-style="western"><surname>Cachianes</surname><given-names>G.</given-names></name><name name-style="western"><surname>Kuang</surname><given-names>W.J.</given-names></name><name name-style="western"><surname>Goeddel</surname><given-names>D.V.</given-names></name><name name-style="western"><surname>Ferrara</surname><given-names>N.</given-names></name></person-group><article-title>Vascular endothelial growth factor is a secreted angiogenic mitogen</article-title><source>Science (80-)</source><volume>246</volume><year>1989</year><fpage>1306</fpage><lpage>1309</lpage><pub-id pub-id-type="doi">10.1126/science.2479986</pub-id><pub-id pub-id-type="pmid">2479986</pub-id></element-citation></ref><ref id="b0475"><label>95</label><element-citation publication-type="journal" id="h0475"><person-group person-group-type="author"><name name-style="western"><surname>Dvorak</surname><given-names>H.F.</given-names></name><name name-style="western"><surname>Brown</surname><given-names>L.F.</given-names></name><name name-style="western"><surname>Detmar</surname><given-names>M.</given-names></name><name name-style="western"><surname>Dvorak</surname><given-names>A.M.</given-names></name></person-group><article-title>Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis</article-title><source>Am J Pathol</source><volume>146</volume><year>1995</year><fpage>1029</fpage><lpage>1039</lpage><pub-id pub-id-type="pmid">7538264</pub-id><pub-id pub-id-type="pmcid">PMC1869291</pub-id></element-citation></ref><ref id="b0480"><label>96</label><element-citation publication-type="journal" id="h0480"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>R.</given-names></name><name name-style="western"><surname>Thomas</surname><given-names>G.R.</given-names></name><name name-style="western"><surname>Bunting</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ko</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ferrara</surname><given-names>N.</given-names></name><name name-style="western"><surname>Keyt</surname><given-names>B.</given-names></name></person-group><article-title>Effects of vascular endothelial growth factor on hemodynamics and cardiac performance</article-title><source>J Cardiovasc Pharmacol</source><volume>27</volume><year>1996</year><fpage>838</fpage><lpage>844</lpage><pub-id pub-id-type="doi">10.1097/00005344-199606000-00011</pub-id><pub-id pub-id-type="pmid">8761851</pub-id></element-citation></ref><ref id="b0485"><label>97</label><element-citation publication-type="journal" id="h0485"><person-group person-group-type="author"><name name-style="western"><surname>Bhandari</surname><given-names>V.</given-names></name><name name-style="western"><surname>Choo-Wing</surname><given-names>R.</given-names></name><name name-style="western"><surname>Chapoval</surname><given-names>S.P.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>C.G.</given-names></name><name name-style="western"><surname>Tang</surname><given-names>C.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>Y.K.</given-names></name></person-group><article-title>Essential role of nitric oxide in VEGF-induced, asthma-like angiogenic, inflammatory, mucus, and physiologic responses in the lung</article-title><source>Proc Natl Acad Sci U S A</source><volume>103</volume><year>2006</year><fpage>11021</fpage><lpage>11026</lpage><pub-id pub-id-type="doi">10.1073/pnas.0601057103</pub-id><pub-id pub-id-type="pmid">16832062</pub-id><pub-id pub-id-type="pmcid">PMC1544167</pub-id></element-citation></ref><ref id="b0490"><label>98</label><element-citation publication-type="journal" id="h0490"><person-group person-group-type="author"><name name-style="western"><surname>Thickett</surname><given-names>D.R.</given-names></name><name name-style="western"><surname>Armstrong</surname><given-names>L.</given-names></name><name name-style="western"><surname>Christie</surname><given-names>S.J.</given-names></name><name name-style="western"><surname>Millar</surname><given-names>A.B.</given-names></name></person-group><article-title>Vascular endothelial growth factor may contribute to increased vascular permeability in acute respiratory distress syndrome</article-title><source>Am J Respir Crit Care Med</source><volume>164</volume><year>2001</year><fpage>1601</fpage><lpage>1605</lpage><pub-id pub-id-type="doi">10.1164/ajrccm.164.9.2011071</pub-id><pub-id pub-id-type="pmid">11719296</pub-id></element-citation></ref><ref id="b0495"><label>99</label><element-citation publication-type="journal" id="h0495"><person-group person-group-type="author"><name name-style="western"><surname>Kaner</surname><given-names>R.J.</given-names></name><name name-style="western"><surname>Ladetto</surname><given-names>J.V.</given-names></name><name name-style="western"><surname>Singh</surname><given-names>R.</given-names></name><name name-style="western"><surname>Fukuda</surname><given-names>N.</given-names></name><name name-style="western"><surname>Matthay</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Crystal</surname><given-names>R.G.</given-names></name></person-group><article-title>Lung overexpression of the vascular endothelial growth factor gene induces pulmonary edema</article-title><source>Am J Respir Cell Mol Biol</source><volume>22</volume><year>2000</year><fpage>657</fpage><lpage>664</lpage><pub-id pub-id-type="doi">10.1165/ajrcmb.22.6.3779</pub-id><pub-id pub-id-type="pmid">10837361</pub-id></element-citation></ref><ref id="b0500"><label>100</label><element-citation publication-type="journal" id="h0500"><person-group person-group-type="author"><name name-style="western"><surname>Epiphanio</surname><given-names>S.</given-names></name><name name-style="western"><surname>Campos</surname><given-names>M.G.</given-names></name><name name-style="western"><surname>Pamplona</surname><given-names>A.</given-names></name><name name-style="western"><surname>Carapau</surname><given-names>D.</given-names></name><name name-style="western"><surname>Pena</surname><given-names>A.C.</given-names></name><name name-style="western"><surname>Ata&#237;de</surname><given-names>R.</given-names></name></person-group><article-title>VEGF promotes malaria-associated acute lung injury in Mice</article-title><source>PLoS Pathog</source><volume>6</volume><year>2010</year><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1371/journal.ppat.1000916</pub-id><pub-id pub-id-type="pmcid">PMC2873913</pub-id><pub-id pub-id-type="pmid">20502682</pub-id></element-citation></ref><ref id="b0505"><label>101</label><element-citation publication-type="journal" id="h0505"><person-group person-group-type="author"><name name-style="western"><surname>Gonzales</surname><given-names>J.N.</given-names></name><name name-style="western"><surname>Lucas</surname><given-names>R.</given-names></name><name name-style="western"><surname>Verin</surname><given-names>A.D.</given-names></name></person-group><article-title>The acute respiratory distress syndrome: mechanisms and perspective therapeutic approaches</article-title><source>Austin J Vasc Med</source><volume>2</volume><year>2015</year><pub-id pub-id-type="pmcid">PMC4786180</pub-id><pub-id pub-id-type="pmid">26973981</pub-id></element-citation></ref><ref id="b0510"><label>102</label><element-citation publication-type="journal" id="h0510"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>G.</given-names></name><name name-style="western"><surname>Hamacher</surname><given-names>J.</given-names></name><name name-style="western"><surname>Gorshkov</surname><given-names>B.</given-names></name><name name-style="western"><surname>White</surname><given-names>R.</given-names></name><name name-style="western"><surname>Sridhar</surname><given-names>S.</given-names></name><name name-style="western"><surname>Verin</surname><given-names>A.</given-names></name></person-group><article-title>The dual role of TNF in pulmonary edema</article-title><source>J Cardiovasc Dis Res</source><volume>1</volume><year>2010</year><fpage>29</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.4103/0975-3583.59983</pub-id><pub-id pub-id-type="pmid">21188088</pub-id><pub-id pub-id-type="pmcid">PMC3004168</pub-id></element-citation></ref><ref id="b0515"><label>103</label><element-citation publication-type="journal" id="h0515"><person-group person-group-type="author"><name name-style="western"><surname>Egli</surname><given-names>M.</given-names></name><name name-style="western"><surname>Duplain</surname><given-names>H.</given-names></name><name name-style="western"><surname>Lepori</surname><given-names>M.</given-names></name><name name-style="western"><surname>Cook</surname><given-names>S.</given-names></name><name name-style="western"><surname>Nicod</surname><given-names>P.</given-names></name><name name-style="western"><surname>Hummler</surname><given-names>E.</given-names></name></person-group><article-title>Defective respiratory amiloride-sensitive sodium transport predisposes to pulmonary oedema and delays its resolution in mice</article-title><source>J Physiol</source><volume>560</volume><year>2004</year><fpage>857</fpage><lpage>865</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.2004.066704</pub-id><pub-id pub-id-type="pmid">15308680</pub-id><pub-id pub-id-type="pmcid">PMC1665279</pub-id></element-citation></ref><ref id="b0520"><label>104</label><element-citation publication-type="journal" id="h0520"><person-group person-group-type="author"><name name-style="western"><surname>Olivier</surname><given-names>R.</given-names></name><name name-style="western"><surname>Scherrer</surname><given-names>U.</given-names></name><name name-style="western"><surname>Horisberger</surname><given-names>J.D.</given-names></name><name name-style="western"><surname>Rossier</surname><given-names>B.C.</given-names></name><name name-style="western"><surname>Hummler</surname><given-names>E.</given-names></name></person-group><article-title>Selected contribution: limiting Na+ transport rate in airway epithelia from &#945;-ENaC transgenic mice: a model for pulmonary edema</article-title><source>J Appl Physiol</source><volume>93</volume><year>2002</year><fpage>1881</fpage><lpage>1887</lpage><pub-id pub-id-type="doi">10.1152/japplphysiol.00413.2002</pub-id><pub-id pub-id-type="pmid">12381779</pub-id></element-citation></ref><ref id="b0525"><label>105</label><element-citation publication-type="journal" id="h0525"><person-group person-group-type="author"><name name-style="western"><surname>Looney</surname><given-names>M.R.</given-names></name><name name-style="western"><surname>Sartori</surname><given-names>C.</given-names></name><name name-style="western"><surname>Chakraborty</surname><given-names>S.</given-names></name><name name-style="western"><surname>James</surname><given-names>P.F.</given-names></name><name name-style="western"><surname>Lingrel</surname><given-names>J.B.</given-names></name><name name-style="western"><surname>Matthay</surname><given-names>M.A.</given-names></name></person-group><article-title>Decreased expression of both the &#945;1- and &#945;2-subunits of the Na-K-ATPase reduces maximal alveolar epithelial fluid clearance</article-title><source>Am J Physiol &#8211; Lung Cell Mol Physiol</source><volume>289</volume><year>2005</year><fpage>104</fpage><lpage>110</lpage><pub-id pub-id-type="doi">10.1152/ajplung.00464.2004</pub-id><pub-id pub-id-type="pmid">15781423</pub-id></element-citation></ref><ref id="b0530"><label>106</label><element-citation publication-type="journal" id="h0530"><person-group person-group-type="author"><name name-style="western"><surname>Matalon</surname><given-names>S.</given-names></name><name name-style="western"><surname>O&#8217;Brodovich</surname><given-names>H.</given-names></name></person-group><article-title>Sodium channels in alveolar epithelial cells: molecular characterization, biophysical properties, and physiological significance</article-title><source>Annu Rev Physiol</source><volume>61</volume><year>1999</year><fpage>627</fpage><lpage>661</lpage><pub-id pub-id-type="doi">10.1146/annurev.physiol.61.1.627</pub-id><pub-id pub-id-type="pmid">10099704</pub-id></element-citation></ref><ref id="b0535"><label>107</label><element-citation publication-type="journal" id="h0535"><person-group person-group-type="author"><name name-style="western"><surname>Matthay</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Folkesson</surname><given-names>H.G.</given-names></name><name name-style="western"><surname>Clerici</surname><given-names>C.</given-names></name></person-group><article-title>Lung epithelial fluid transport and the resolution of pulmonary edema</article-title><source>Physiol Rev</source><volume>82</volume><year>2002</year><fpage>569</fpage><lpage>600</lpage><pub-id pub-id-type="doi">10.1152/physrev.00003.2002</pub-id><pub-id pub-id-type="pmid">12087129</pub-id></element-citation></ref><ref id="b0540"><label>108</label><element-citation publication-type="journal" id="h0540"><person-group person-group-type="author"><name name-style="western"><surname>Sznajder</surname><given-names>J.I.</given-names></name><name name-style="western"><surname>Factor</surname><given-names>P.</given-names></name><name name-style="western"><surname>Ingbar</surname><given-names>D.H.</given-names></name></person-group><article-title>Invited review: lung edema clearance: Role of Na+-K+-ATPase</article-title><source>J Appl Physiol</source><volume>93</volume><year>2002</year><fpage>1860</fpage><lpage>1866</lpage><pub-id pub-id-type="doi">10.1152/japplphysiol.00022.2002</pub-id><pub-id pub-id-type="pmid">12381775</pub-id></element-citation></ref><ref id="b0545"><label>109</label><element-citation publication-type="journal" id="h0545"><person-group person-group-type="author"><name name-style="western"><surname>Sidhaye</surname><given-names>V.K.</given-names></name><name name-style="western"><surname>G&#252;ler</surname><given-names>A.D.</given-names></name><name name-style="western"><surname>Schweitzer</surname><given-names>K.S.</given-names></name><name name-style="western"><surname>D&#8217;Alessio</surname><given-names>F.</given-names></name><name name-style="western"><surname>Caterina</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>King</surname><given-names>L.S.</given-names></name></person-group><article-title>Transient receptor potential vanilloid 4 regulates aquaporin-5 abundance under hypotonic conditions</article-title><source>Proc Natl Acad Sci U S A</source><volume>103</volume><year>2006</year><fpage>4747</fpage><lpage>4752</lpage><pub-id pub-id-type="doi">10.1073/pnas.0511211103</pub-id><pub-id pub-id-type="pmid">16537379</pub-id><pub-id pub-id-type="pmcid">PMC1450241</pub-id></element-citation></ref><ref id="b0550"><label>110</label><element-citation publication-type="journal" id="h0550"><person-group person-group-type="author"><name name-style="western"><surname>Krane</surname><given-names>C.M.</given-names></name><name name-style="western"><surname>Melvin</surname><given-names>J.E.</given-names></name><name name-style="western"><surname>Van</surname><given-names>Nguyen H</given-names></name><name name-style="western"><surname>Richardson</surname><given-names>L.</given-names></name><name name-style="western"><surname>Towne</surname><given-names>J.E.</given-names></name><name name-style="western"><surname>Doetschman</surname><given-names>T.</given-names></name></person-group><article-title>Salivary acinar cells from aquaporin 5-deficient mice have decreased membrane water permeability and altered cell volume regulation</article-title><source>J Biol Chem</source><volume>276</volume><year>2001</year><fpage>23413</fpage><lpage>23420</lpage><pub-id pub-id-type="doi">10.1074/jbc.M008760200</pub-id><pub-id pub-id-type="pmid">11290736</pub-id></element-citation></ref><ref id="b0555"><label>111</label><element-citation publication-type="journal" id="h0555"><person-group person-group-type="author"><name name-style="western"><surname>Rump</surname><given-names>K.</given-names></name><name name-style="western"><surname>Adamzik</surname><given-names>M.</given-names></name></person-group><article-title>Function of aquaporins in sepsis: a systematic review</article-title><source>Cell Biosci</source><volume>8</volume><year>2018</year><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1186/s13578-018-0211-9</pub-id><pub-id pub-id-type="pmid">29449936</pub-id><pub-id pub-id-type="pmcid">PMC5807818</pub-id></element-citation></ref><ref id="b0560"><label>112</label><element-citation publication-type="journal" id="h0560"><person-group person-group-type="author"><name name-style="western"><surname>Gao</surname><given-names>J.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>L.</given-names></name><name name-style="western"><surname>Ge</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Lin</surname><given-names>S.</given-names></name><name name-style="western"><surname>Du</surname><given-names>J.</given-names></name></person-group><article-title>Effects of different resuscitation fluids on pulmonary expression of aquaporin1 and aquaporin5 in a rat model of uncontrolled hemorrhagic shock and infection</article-title><source>PLoS ONE</source><volume>8</volume><year>2013</year><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1371/journal.pone.0064390</pub-id><pub-id pub-id-type="pmcid">PMC3669317</pub-id><pub-id pub-id-type="pmid">23741323</pub-id></element-citation></ref><ref id="b0565"><label>113</label><element-citation publication-type="journal" id="h0565"><person-group person-group-type="author"><name name-style="western"><surname>Towne</surname><given-names>J.E.</given-names></name><name name-style="western"><surname>Harrod</surname><given-names>K.S.</given-names></name><name name-style="western"><surname>Krane</surname><given-names>C.M.</given-names></name><name name-style="western"><surname>Menon</surname><given-names>A.G.</given-names></name></person-group><article-title>Decreased expression of aquaporin (AQP)1 and AQP5 in mouse lung after acute viral infection</article-title><source>Am J Respir Cell Mol Biol</source><volume>22</volume><year>2000</year><fpage>34</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1165/ajrcmb.22.1.3818</pub-id><pub-id pub-id-type="pmid">10615063</pub-id></element-citation></ref><ref id="b0570"><label>114</label><element-citation publication-type="journal" id="h0570"><person-group person-group-type="author"><name name-style="western"><surname>Vassiliou</surname><given-names>A.G.</given-names></name><name name-style="western"><surname>Manitsopoulos</surname><given-names>N.</given-names></name><name name-style="western"><surname>Kardara</surname><given-names>M.</given-names></name><name name-style="western"><surname>Maniatis</surname><given-names>N.A.</given-names></name><name name-style="western"><surname>Orfanos</surname><given-names>S.E.</given-names></name><name name-style="western"><surname>Kotanidou</surname><given-names>A.</given-names></name></person-group><article-title>Differential expression of aquaporins in experimental models of acute lung injury</article-title><source>Vivo (Brooklyn)</source><volume>31</volume><year>2017</year><fpage>885</fpage><lpage>894</lpage><pub-id pub-id-type="doi">10.21873/invivo.11143</pub-id><pub-id pub-id-type="pmcid">PMC5656862</pub-id><pub-id pub-id-type="pmid">28882955</pub-id></element-citation></ref><ref id="b0575"><label>115</label><element-citation publication-type="journal" id="h0575"><person-group person-group-type="author"><name name-style="western"><surname>Towne</surname><given-names>J.E.</given-names></name><name name-style="western"><surname>Krane</surname><given-names>C.M.</given-names></name><name name-style="western"><surname>Bachurski</surname><given-names>C.J.</given-names></name><name name-style="western"><surname>Menon</surname><given-names>A.G.</given-names></name></person-group><article-title>Tumor necrosis factor-&#945; inhibits aquaporin 5 expression in mouse lung epithelial cells</article-title><source>J Biol Chem</source><volume>276</volume><year>2001</year><fpage>18657</fpage><lpage>18664</lpage><pub-id pub-id-type="doi">10.1074/jbc.M100322200</pub-id><pub-id pub-id-type="pmid">11279049</pub-id></element-citation></ref><ref id="b0580"><label>116</label><element-citation publication-type="journal" id="h0580"><person-group person-group-type="author"><name name-style="western"><surname>Ledgerwood</surname><given-names>E.C.</given-names></name><name name-style="western"><surname>Pober</surname><given-names>J.S.</given-names></name><name name-style="western"><surname>Bradley</surname><given-names>J.R.</given-names></name></person-group><article-title>Recent advances in the molecular basis of TNF signal transduction</article-title><source>Lab Investig</source><volume>79</volume><year>1999</year><fpage>1041</fpage><lpage>1050</lpage><pub-id pub-id-type="pmid">10496522</pub-id></element-citation></ref><ref id="b0585"><label>117</label><element-citation publication-type="journal" id="h0585"><person-group person-group-type="author"><name name-style="western"><surname>Darnay</surname><given-names>B.G.</given-names></name><name name-style="western"><surname>Aggarwal</surname><given-names>B.B.</given-names></name></person-group><article-title>Signal transduction by tumour necrosis factor and tumour necrosis factor related ligands and their receptors</article-title><source>Ann Rheum Dis</source><volume>58</volume><year>1999</year><pub-id pub-id-type="doi">10.1136/ard.58.2008.i2</pub-id><pub-id pub-id-type="pmcid">PMC1766589</pub-id><pub-id pub-id-type="pmid">10577967</pub-id></element-citation></ref><ref id="b0590"><label>118</label><element-citation publication-type="journal" id="h0590"><person-group person-group-type="author"><name name-style="western"><surname>Eder</surname><given-names>J.</given-names></name></person-group><article-title>Tumour necrosis factor &#945; and interleukin 1 signalling: do MAPKK kinases connect it all?</article-title><source>Trends Pharmacol Sci</source><volume>18</volume><year>1997</year><fpage>319</fpage><lpage>322</lpage><pub-id pub-id-type="doi">10.1016/S0165-6147(97)01097-3</pub-id><pub-id pub-id-type="pmid">9345850</pub-id></element-citation></ref><ref id="b0595"><label>119</label><element-citation publication-type="journal" id="h0595"><person-group person-group-type="author"><name name-style="western"><surname>Kreimeier</surname><given-names>U.</given-names></name><name name-style="western"><surname>Messmer</surname><given-names>K.</given-names></name></person-group><article-title>Small-volume resuscitation: From experimental evidence to clinical routine. Advantages and disadvantages of hypertonic solutions</article-title><source>Acta Anaesthesiol Scand</source><volume>46</volume><year>2002</year><fpage>625</fpage><lpage>638</lpage><pub-id pub-id-type="doi">10.1034/j.1399-6576.2002.460601.x</pub-id><pub-id pub-id-type="pmid">12059884</pub-id></element-citation></ref><ref id="b0600"><label>120</label><element-citation publication-type="journal" id="h0600"><person-group person-group-type="author"><name name-style="western"><surname>Powers</surname><given-names>K.A.</given-names></name><name name-style="western"><surname>Woo</surname><given-names>J.</given-names></name><name name-style="western"><surname>Khadaroo</surname><given-names>R.G.</given-names></name><name name-style="western"><surname>Papia</surname><given-names>G.</given-names></name><name name-style="western"><surname>Kapus</surname><given-names>A.</given-names></name><name name-style="western"><surname>Rotstein</surname><given-names>O.D.</given-names></name></person-group><article-title>Hypertonic resuscitation of hemorrhagic shock upregulates the anti-inflammatory response by alveolar macrophages</article-title><source>Surgery</source><volume>134</volume><year>2003</year><fpage>312</fpage><lpage>318</lpage><pub-id pub-id-type="doi">10.1067/msy.2003.246</pub-id><pub-id pub-id-type="pmid">12947335</pub-id></element-citation></ref><ref id="b0605"><label>121</label><element-citation publication-type="journal" id="h0605"><person-group person-group-type="author"><name name-style="western"><surname>Wohlauer</surname><given-names>M.</given-names></name><name name-style="western"><surname>Moore</surname><given-names>E.E.</given-names></name><name name-style="western"><surname>Silliman</surname><given-names>C.C.</given-names></name><name name-style="western"><surname>Fragoso</surname><given-names>M.</given-names></name><name name-style="western"><surname>Gamboni</surname><given-names>F.</given-names></name><name name-style="western"><surname>Harr</surname><given-names>J.</given-names></name></person-group><article-title>Nebulized hypertonic saline attenuates acute lung injury following trauma and hemorrhagic shock via inhibition of matrix metalloproteinase-13</article-title><source>Crit Care Med</source><volume>40</volume><year>2012</year><fpage>2647</fpage><lpage>2653</lpage><pub-id pub-id-type="doi">10.1097/CCM.0b013e3182592006</pub-id><pub-id pub-id-type="pmid">22732292</pub-id><pub-id pub-id-type="pmcid">PMC3519396</pub-id></element-citation></ref><ref id="b0610"><label>122</label><element-citation publication-type="journal" id="h0610"><person-group person-group-type="author"><name name-style="western"><surname>Rosenberg</surname><given-names>A.L.</given-names></name><name name-style="western"><surname>Dechert</surname><given-names>R.E.</given-names></name><name name-style="western"><surname>Park</surname><given-names>P.K.</given-names></name><name name-style="western"><surname>Bartlett</surname><given-names>R.H.</given-names></name></person-group><article-title>Review of a large clinical series: association of cumulative fluid balance on outcome in acute lung injury: a retrospective review of the ARDSnet tidal volume study cohort</article-title><source>J Intensive Care Med</source><volume>24</volume><year>2009</year><fpage>35</fpage><lpage>46</lpage><pub-id pub-id-type="pmid">19103612</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/0885066608329850</pub-id></element-citation></ref><ref id="b0615"><label>123</label><element-citation publication-type="journal" id="h0615"><person-group person-group-type="author"><name name-style="western"><surname>Wiedemann</surname><given-names>H.P.</given-names></name><name name-style="western"><surname>Wheeler</surname><given-names>A.P.</given-names></name><name name-style="western"><surname>Bernard</surname><given-names>G.R.</given-names></name><name name-style="western"><surname>Thompson</surname><given-names>B.T.</given-names></name><name name-style="western"><surname>Hayden</surname><given-names>D.</given-names></name><name name-style="western"><surname>DeBoisblanc</surname><given-names>B.</given-names></name></person-group><article-title>Comparison of two fluid-management strategies in acute lung injury</article-title><source>N Engl J Med</source><volume>354</volume><year>2006</year><fpage>2564</fpage><lpage>2575</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa062200</pub-id><pub-id pub-id-type="pmid">16714767</pub-id></element-citation></ref><ref id="b0620"><label>124</label><mixed-citation publication-type="other" id="h0620">NHLBI ARDS Network|About n.d. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ardsnet.org/" id="ir065">http://www.ardsnet.org/</ext-link> (accessed May 1, 2020).</mixed-citation></ref><ref id="b0625"><label>125</label><element-citation publication-type="journal" id="h0625"><person-group person-group-type="author"><name name-style="western"><surname>Jerng</surname><given-names>J.S.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>C.J.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>H.C.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>K.Y.</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>S.L.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>P.C.</given-names></name></person-group><article-title>Polymorphism of the angiotensin-converting enzyme gene affects the outcome of acute respiratory distress syndrome</article-title><source>Crit Care Med</source><volume>34</volume><year>2006</year><fpage>1001</fpage><lpage>1006</lpage><pub-id pub-id-type="pmid">16484896</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/01.CCM.0000206107.92476.39</pub-id></element-citation></ref><ref id="b0630"><label>126</label><element-citation publication-type="journal" id="h0630"><person-group person-group-type="author"><name name-style="western"><surname>Marshall</surname><given-names>R.P.</given-names></name><name name-style="western"><surname>Webb</surname><given-names>S.</given-names></name><name name-style="western"><surname>Bellingan</surname><given-names>G.J.</given-names></name><name name-style="western"><surname>Montgomery</surname><given-names>H.E.</given-names></name><name name-style="western"><surname>Chaudhari</surname><given-names>B.</given-names></name><name name-style="western"><surname>McAnulty</surname><given-names>R.J.</given-names></name></person-group><article-title>Angiotensin converting enzyme insertion/deletion polymorphism is associated with susceptibility and outcome in acute respiratory distress syndrome</article-title><source>Am J Respir Crit Care Med</source><volume>166</volume><year>2002</year><fpage>646</fpage><lpage>650</lpage><pub-id pub-id-type="doi">10.1164/rccm.2108086</pub-id><pub-id pub-id-type="pmid">12204859</pub-id></element-citation></ref><ref id="b0635"><label>127</label><element-citation publication-type="journal" id="h0635"><person-group person-group-type="author"><name name-style="western"><surname>Adamzik</surname><given-names>M.</given-names></name><name name-style="western"><surname>Frey</surname><given-names>U.H.</given-names></name><name name-style="western"><surname>Bitzer</surname><given-names>K.</given-names></name><name name-style="western"><surname>Jakob</surname><given-names>H.</given-names></name><name name-style="western"><surname>Baba</surname><given-names>H.A.</given-names></name><name name-style="western"><surname>Schmieder</surname><given-names>R.E.</given-names></name></person-group><article-title>A novel-1364A/C aquaporin 5 gene promoter polymorphism influences the responses to salt loading of the renin-angiotensin-aldosterone system and of blood pressure in young healthy men</article-title><source>Basic Res Cardiol</source><volume>103</volume><year>2008</year><fpage>598</fpage><lpage>610</lpage><pub-id pub-id-type="doi">10.1007/s00395-008-0750-z</pub-id><pub-id pub-id-type="pmid">18846354</pub-id></element-citation></ref><ref id="b0640"><label>128</label><element-citation publication-type="journal" id="h0640"><person-group person-group-type="author"><name name-style="western"><surname>Adamzik</surname><given-names>M.</given-names></name><name name-style="western"><surname>Frey</surname><given-names>U.H.</given-names></name><name name-style="western"><surname>M&#246;hlenkamp</surname><given-names>S.</given-names></name><name name-style="western"><surname>Scherag</surname><given-names>A.</given-names></name><name name-style="western"><surname>Waydhas</surname><given-names>C.</given-names></name><name name-style="western"><surname>Marggraf</surname><given-names>G.</given-names></name></person-group><article-title>Aquaporin 5 gene promoter 1364A/C polymorphism associated with 30-day survival in severe sepsis</article-title><source>Anesthesiology</source><volume>114</volume><year>2011</year><fpage>912</fpage><lpage>917</lpage><pub-id pub-id-type="doi">10.1097/ALN.0b013e31820ca911</pub-id><pub-id pub-id-type="pmid">21427539</pub-id></element-citation></ref><ref id="b0645"><label>129</label><element-citation publication-type="journal" id="h0645"><person-group person-group-type="author"><name name-style="western"><surname>Lang</surname><given-names>F.</given-names></name><name name-style="western"><surname>Guelinckx</surname><given-names>I.</given-names></name><name name-style="western"><surname>Lemetais</surname><given-names>G.</given-names></name><name name-style="western"><surname>Melander</surname><given-names>O.</given-names></name></person-group><article-title>Two liters a day keep the doctor away? Considerations on the pathophysiology of suboptimal fluid intake in the common population</article-title><source>Kidney Blood Press Res</source><volume>42</volume><year>2017</year><fpage>483</fpage><lpage>494</lpage><pub-id pub-id-type="doi">10.1159/000479640</pub-id><pub-id pub-id-type="pmid">28787716</pub-id></element-citation></ref><ref id="b0650"><label>130</label><element-citation publication-type="journal" id="h0650"><person-group person-group-type="author"><name name-style="western"><surname>Armstrong</surname><given-names>L.E.</given-names></name></person-group><article-title>Assessing hydration status: the elusive gold standard</article-title><source>J Am Coll Nutr</source><volume>26</volume><year>2007</year><fpage>575S</fpage><lpage>584S</lpage><pub-id pub-id-type="doi">10.1080/07315724.2007.10719661</pub-id><pub-id pub-id-type="pmid">17921468</pub-id></element-citation></ref><ref id="b0655"><label>131</label><element-citation publication-type="journal" id="h0655"><person-group person-group-type="author"><name name-style="western"><surname>Lang</surname><given-names>F.</given-names></name><name name-style="western"><surname>Stournaras</surname><given-names>C.</given-names></name><name name-style="western"><surname>Alesutan</surname><given-names>I.</given-names></name></person-group><article-title>Regulation of transport across cell membranes by the serum-and glucocorticoid-inducible kinase SGK1</article-title><source>Mol Membr Biol</source><volume>31</volume><year>2014</year><fpage>29</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.3109/09687688.2013.874598</pub-id><pub-id pub-id-type="pmid">24417516</pub-id></element-citation></ref><ref id="b0660"><label>132</label><element-citation publication-type="journal" id="h0660"><person-group person-group-type="author"><name name-style="western"><surname>Lang</surname><given-names>F.</given-names></name><name name-style="western"><surname>Stournaras</surname><given-names>C.</given-names></name></person-group><article-title>Serum and glucocorticoid inducible kinase, metabolic syndrome, inflammation, and tumor growth</article-title><source>Hormones</source><volume>12</volume><year>2013</year><fpage>160</fpage><lpage>171</lpage><pub-id pub-id-type="doi">10.14310/horm.2002.1401</pub-id><pub-id pub-id-type="pmid">23933686</pub-id></element-citation></ref><ref id="b0665"><label>133</label><element-citation publication-type="journal" id="h0665"><person-group person-group-type="author"><name name-style="western"><surname>Lang</surname><given-names>F.</given-names></name><name name-style="western"><surname>B&#246;hmer</surname><given-names>C.</given-names></name><name name-style="western"><surname>Palmada</surname><given-names>M.</given-names></name><name name-style="western"><surname>Seebohm</surname><given-names>G.</given-names></name><name name-style="western"><surname>Strutz-Seebohm</surname><given-names>N.</given-names></name><name name-style="western"><surname>Vallon</surname><given-names>V.</given-names></name></person-group><article-title>(Patho)physiological significance of the serum- and glucocorticoid- inducible kinase isoforms</article-title><source>Physiol Rev</source><volume>86</volume><year>2006</year><fpage>1151</fpage><lpage>1178</lpage><pub-id pub-id-type="doi">10.1152/physrev.00050.2005</pub-id><pub-id pub-id-type="pmid">17015487</pub-id></element-citation></ref><ref id="b0670"><label>134</label><element-citation publication-type="journal" id="h0670"><person-group person-group-type="author"><name name-style="western"><surname>Shih</surname><given-names>V.F.S.</given-names></name><name name-style="western"><surname>Tsui</surname><given-names>R.</given-names></name><name name-style="western"><surname>Caldwell</surname><given-names>A.</given-names></name><name name-style="western"><surname>Hoffmann</surname><given-names>A.</given-names></name></person-group><article-title>A single NF&#954;B system for both canonical and non-canonical signaling</article-title><source>Cell Res</source><volume>21</volume><year>2011</year><fpage>86</fpage><lpage>102</lpage><pub-id pub-id-type="doi">10.1038/cr.2010.161</pub-id><pub-id pub-id-type="pmid">21102550</pub-id><pub-id pub-id-type="pmcid">PMC3193412</pub-id></element-citation></ref><ref id="b0675"><label>135</label><element-citation publication-type="journal" id="h0675"><person-group person-group-type="author"><name name-style="western"><surname>Stone</surname><given-names>K.P.</given-names></name><name name-style="western"><surname>Kastin</surname><given-names>A.J.</given-names></name><name name-style="western"><surname>Pan</surname><given-names>W.</given-names></name></person-group><article-title>NF&#954;B is an unexpected major mediator of interleukin-15 signaling in cerebral endothelia</article-title><source>Cell Physiol Biochem</source><volume>28</volume><year>2011</year><fpage>115</fpage><lpage>124</lpage><pub-id pub-id-type="pmid">21865854</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1159/000331720</pub-id><pub-id pub-id-type="pmcid">PMC3709181</pub-id></element-citation></ref><ref id="b0680"><label>136</label><element-citation publication-type="journal" id="h0680"><person-group person-group-type="author"><name name-style="western"><surname>Cheng</surname><given-names>J.</given-names></name><name name-style="western"><surname>Truong</surname><given-names>L.D.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>X.</given-names></name><name name-style="western"><surname>Kuhl</surname><given-names>D.</given-names></name><name name-style="western"><surname>Lang</surname><given-names>F.</given-names></name><name name-style="western"><surname>Du</surname><given-names>J.</given-names></name></person-group><article-title>Serum- and glucocorticoid-regulated kinase 1 is upregulated following unilateral ureteral obstruction causing epithelial-mesenchymal transition</article-title><source>Kidney Int</source><volume>78</volume><year>2010</year><fpage>668</fpage><lpage>678</lpage><pub-id pub-id-type="doi">10.1038/ki.2010.214</pub-id><pub-id pub-id-type="pmid">20631674</pub-id><pub-id pub-id-type="pmcid">PMC3935313</pub-id></element-citation></ref><ref id="b0685"><label>137</label><element-citation publication-type="journal" id="h0685"><person-group person-group-type="author"><name name-style="western"><surname>Akhurst</surname><given-names>R.J.</given-names></name><name name-style="western"><surname>Hata</surname><given-names>A.</given-names></name></person-group><article-title>Targeting the TGF&#946; signalling pathway in disease</article-title><source>Nat Rev Drug Discov</source><volume>11</volume><year>2012</year><fpage>790</fpage><lpage>811</lpage><pub-id pub-id-type="doi">10.1038/nrd3810</pub-id><pub-id pub-id-type="pmid">23000686</pub-id><pub-id pub-id-type="pmcid">PMC3520610</pub-id></element-citation></ref><ref id="b0690"><label>138</label><element-citation publication-type="journal" id="h0690"><person-group person-group-type="author"><name name-style="western"><surname>Bikdeli</surname><given-names>B.</given-names></name><name name-style="western"><surname>Madhavan</surname><given-names>M.V.</given-names></name><name name-style="western"><surname>Jimenez</surname><given-names>D.</given-names></name><name name-style="western"><surname>Chuich</surname><given-names>T.</given-names></name><name name-style="western"><surname>Dreyfus</surname><given-names>I.</given-names></name><name name-style="western"><surname>Driggin</surname><given-names>E.</given-names></name></person-group><article-title>COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review</article-title><source>J Am Coll Cardiol</source><volume>75</volume><year>2020</year><fpage>2950</fpage><lpage>2973</lpage><pub-id pub-id-type="doi">10.1016/j.jacc.2020.04.031</pub-id><pub-id pub-id-type="pmid">32311448</pub-id><pub-id pub-id-type="pmcid">PMC7164881</pub-id></element-citation></ref><ref id="b0695"><label>139</label><element-citation publication-type="journal" id="h0695"><person-group person-group-type="author"><name name-style="western"><surname>Fortes</surname><given-names>M.B.</given-names></name><name name-style="western"><surname>Owen</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Raymond-Barker</surname><given-names>P.</given-names></name><name name-style="western"><surname>Bishop</surname><given-names>C.</given-names></name><name name-style="western"><surname>Elghenzai</surname><given-names>S.</given-names></name><name name-style="western"><surname>Oliver</surname><given-names>S.J.</given-names></name></person-group><article-title>Is this elderly patient dehydrated? Diagnostic accuracy of hydration assessment using physical signs, urine, and saliva markers</article-title><source>J Am Med Dir Assoc</source><volume>16</volume><year>2015</year><fpage>221</fpage><lpage>228</lpage><pub-id pub-id-type="pmid">25444573</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jamda.2014.09.012</pub-id></element-citation></ref><ref id="b0700"><label>140</label><element-citation publication-type="journal" id="h0700"><person-group person-group-type="author"><name name-style="western"><surname>Cheuvront</surname><given-names>S.N.</given-names></name><name name-style="western"><surname>Ely</surname><given-names>B.R.</given-names></name><name name-style="western"><surname>Kenefick</surname><given-names>R.W.</given-names></name><name name-style="western"><surname>Sawka</surname><given-names>M.N.</given-names></name></person-group><article-title>Biological variation and diagnostic accuracy of dehydration assessment markers</article-title><source>Am J Clin Nutr</source><volume>92</volume><year>2010</year><fpage>565</fpage><lpage>573</lpage><pub-id pub-id-type="pmid">20631205</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3945/ajcn.2010.29490</pub-id></element-citation></ref><ref id="b0705"><label>141</label><element-citation publication-type="journal" id="h0705"><person-group person-group-type="author"><name name-style="western"><surname>Taylor</surname><given-names>N.A.S.</given-names></name><name name-style="western"><surname>Van Den Heuvel</surname><given-names>A.M.J.</given-names></name><name name-style="western"><surname>Kerry</surname><given-names>P.</given-names></name><name name-style="western"><surname>McGhee</surname><given-names>S.</given-names></name><name name-style="western"><surname>Peoples</surname><given-names>G.E.</given-names></name><name name-style="western"><surname>Brown</surname><given-names>M.A.</given-names></name></person-group><article-title>Observations on saliva osmolality during progressive dehydration and partial rehydration</article-title><source>Eur J Appl Physiol</source><volume>112</volume><year>2012</year><fpage>3227</fpage><lpage>3237</lpage><pub-id pub-id-type="doi">10.1007/s00421-011-2299-z</pub-id><pub-id pub-id-type="pmid">22230919</pub-id></element-citation></ref><ref id="b0710"><label>142</label><element-citation publication-type="journal" id="h0710"><person-group person-group-type="author"><name name-style="western"><surname>Ely</surname><given-names>B.R.</given-names></name><name name-style="western"><surname>Cheuvront</surname><given-names>S.N.</given-names></name><name name-style="western"><surname>Kenefick</surname><given-names>R.W.</given-names></name><name name-style="western"><surname>Sawka</surname><given-names>M.N.</given-names></name></person-group><article-title>Limitations of salivary osmolality as a marker of hydration status</article-title><source>Med Sci Sports Exerc</source><volume>43</volume><year>2011</year><fpage>1080</fpage><lpage>1084</lpage><pub-id pub-id-type="pmid">21088626</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1249/MSS.0b013e3182058643</pub-id></element-citation></ref><ref id="b0715"><label>143</label><element-citation publication-type="journal" id="h0715"><person-group person-group-type="author"><name name-style="western"><surname>Lauler</surname><given-names>D.P.</given-names></name><name name-style="western"><surname>Hickler</surname><given-names>R.B.</given-names></name><name name-style="western"><surname>Thorn</surname><given-names>G.</given-names></name></person-group><article-title>The salivary sodium-potassium ratio &#8212; a useful screening test for aldosteronism in hypertensive subjects</article-title><source>N Engl J Med</source><volume>267</volume><year>1962</year><fpage>1136</fpage></element-citation></ref><ref id="b0720"><label>144</label><element-citation publication-type="journal" id="h0720"><person-group person-group-type="author"><name name-style="western"><surname>Riad</surname><given-names>F.</given-names></name><name name-style="western"><surname>Lefaivre</surname><given-names>J.</given-names></name><name name-style="western"><surname>Tournaire</surname><given-names>C.</given-names></name><name name-style="western"><surname>Barlet</surname><given-names>J.P.</given-names></name></person-group><article-title>Aldosterone regulates salivary sodium secretion in cattle</article-title><source>J Endocrinol</source><volume>108</volume><year>1986</year><fpage>405</fpage><lpage>411</lpage><pub-id pub-id-type="doi">10.1677/joe.0.1080405</pub-id><pub-id pub-id-type="pmid">3517212</pub-id></element-citation></ref><ref id="b0725"><label>145</label><mixed-citation publication-type="other" id="h0725">Advice for public n.d. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public" id="ir075">https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public</ext-link> (accessed May 1, 2020).</mixed-citation></ref><ref id="b0730"><label>146</label><mixed-citation publication-type="other" id="h0730">How to Protect Yourself &amp; Others|CDC n.d. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/prevention.html" id="ir080">https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/prevention.html</ext-link> (accessed May 1, 2020).</mixed-citation></ref><ref id="b0740"><label>147</label><element-citation publication-type="journal" id="h0740"><person-group person-group-type="author"><name name-style="western"><surname>Wade</surname><given-names>C.E.</given-names></name><name name-style="western"><surname>Tillman</surname><given-names>F.J.</given-names></name><name name-style="western"><surname>Loveday</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Blackmon</surname><given-names>A.</given-names></name><name name-style="western"><surname>Potanko</surname><given-names>E.</given-names></name><name name-style="western"><surname>Hunt</surname><given-names>M.M.</given-names></name></person-group><article-title>Effect of dehydration on cardiovascular responses and electrolytes after hypertonic saline/dextran treatment for moderate hemorrhage</article-title><source>Ann Emerg Med</source><volume>21</volume><year>1992</year><fpage>113</fpage><lpage>119</lpage><pub-id pub-id-type="doi">10.1016/S0196-0644(05)80143-X</pub-id><pub-id pub-id-type="pmid">1371210</pub-id></element-citation></ref><ref id="b0745"><label>148</label><mixed-citation publication-type="other" id="h0745">Human Rights|UN-Water n.d. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.unwater.org/water-facts/human-rights/" id="ir085">https://www.unwater.org/water-facts/human-rights/</ext-link> (accessed May 15, 2020).</mixed-citation></ref></ref-list><sec id="s0160"><label>Appendix 1</label><title>Biomarkers of status at baseline and change associated with 4&#160;weeks of sustained higher drinking water in 5 healthy young men with initial total water intake below 2L/d who participated in the Adapt study.</title><p id="p0380">
<table-wrap position="anchor" id="t0005" orientation="portrait"><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1"/><th colspan="4" rowspan="1">Biomarkers of chronic hypertonicity<hr/></th><th colspan="2" rowspan="1">Angiogenesis<hr/></th><th colspan="2" rowspan="1">Antioxidant<hr/></th><th colspan="2" rowspan="1">Passive transport<hr/></th><th colspan="2" rowspan="1">Active transport<hr/></th><th colspan="3" rowspan="1">Body water retention<hr/></th></tr><tr><th colspan="1" rowspan="1"/><th colspan="2" rowspan="1">Saliva Osmolality<hr/></th><th colspan="2" rowspan="1">Leukocyte SGK1 mRNA<hr/></th><th colspan="2" rowspan="1">Plasma VEGF<hr/></th><th colspan="2" rowspan="1">RBC GPX<hr/></th><th colspan="2" rowspan="1">Saliva AQP5<hr/></th><th colspan="2" rowspan="1">RBC K:Na<hr/></th><th colspan="2" rowspan="1">Half-life of water in the body<hr/></th><th colspan="1" rowspan="1">Body weight<hr/></th></tr><tr><th colspan="1" rowspan="1"/><th colspan="1" rowspan="1">Baseline</th><th colspan="1" rowspan="1">Change</th><th colspan="1" rowspan="1">Baseline</th><th colspan="1" rowspan="1">Change</th><th colspan="1" rowspan="1">Baseline</th><th colspan="1" rowspan="1">Change</th><th colspan="1" rowspan="1">Baseline</th><th colspan="1" rowspan="1">Change</th><th colspan="1" rowspan="1">Baseline</th><th colspan="1" rowspan="1">Change</th><th colspan="1" rowspan="1">Baseline</th><th colspan="1" rowspan="1">Change</th><th colspan="1" rowspan="1">Baseline</th><th colspan="1" rowspan="1">Change</th><th colspan="1" rowspan="1">Change</th></tr><tr><th colspan="1" rowspan="1"/><th colspan="2" rowspan="1">mmol/kg</th><th colspan="2" rowspan="1">A.U. (2^<sup>-delta</sup> Ct)</th><th colspan="2" rowspan="1">ng/ml</th><th colspan="2" rowspan="1">nmol/min/mg Hb</th><th colspan="2" rowspan="1">ng/ml</th><th colspan="1" rowspan="1"/><th colspan="1" rowspan="1"/><th colspan="2" rowspan="1">Days</th><th colspan="1" rowspan="1">%</th></tr></thead><tbody><tr><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">65</td><td colspan="1" rowspan="1">&#8722;5</td><td colspan="1" rowspan="1">0.060</td><td colspan="1" rowspan="1">&#8722;0.037</td><td colspan="1" rowspan="1">4670.8</td><td colspan="1" rowspan="1">+1878</td><td colspan="1" rowspan="1">462.6</td><td colspan="1" rowspan="1">&#8722;167.3</td><td colspan="1" rowspan="1">0.369</td><td colspan="1" rowspan="1">+1.640</td><td align="char" colspan="1" rowspan="1">8.9</td><td colspan="1" rowspan="1">&#8722;0.57</td><td align="char" colspan="1" rowspan="1">17.9</td><td colspan="1" rowspan="1">&#8722;6.7</td><td colspan="1" rowspan="1">+0.9</td></tr><tr><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">81</td><td colspan="1" rowspan="1">+10</td><td colspan="1" rowspan="1">0.025</td><td colspan="1" rowspan="1">&#8722;0.000</td><td colspan="1" rowspan="1">8807.3</td><td colspan="1" rowspan="1">+767</td><td colspan="1" rowspan="1">596.5</td><td colspan="1" rowspan="1">&#8722;31.1</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">+0.158</td><td align="char" colspan="1" rowspan="1">9.7</td><td colspan="1" rowspan="1">&#8722;0.70</td><td align="char" colspan="1" rowspan="1">15.3</td><td colspan="1" rowspan="1">&#8722;4.7</td><td colspan="1" rowspan="1">+3.0</td></tr><tr><td colspan="1" rowspan="1">3</td><td colspan="1" rowspan="1">106</td><td colspan="1" rowspan="1">&#8722;19</td><td colspan="1" rowspan="1">0.080</td><td colspan="1" rowspan="1">&#8722;0.018</td><td colspan="1" rowspan="1">3731.9</td><td colspan="1" rowspan="1">+1213</td><td colspan="1" rowspan="1">401.8</td><td colspan="1" rowspan="1">+84.0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">+1.82</td><td align="char" colspan="1" rowspan="1">9.3</td><td colspan="1" rowspan="1">&#8722;1.50</td><td align="char" colspan="1" rowspan="1">15.0</td><td colspan="1" rowspan="1">&#8722;1.6</td><td colspan="1" rowspan="1">+2.7</td></tr><tr><td colspan="1" rowspan="1">4</td><td colspan="1" rowspan="1">122</td><td colspan="1" rowspan="1">&#8722;45</td><td colspan="1" rowspan="1">0.067</td><td colspan="1" rowspan="1">&#8722;0.032</td><td colspan="1" rowspan="1">3175.7</td><td colspan="1" rowspan="1">+2823</td><td colspan="1" rowspan="1">455.1</td><td colspan="1" rowspan="1">+163.7</td><td colspan="1" rowspan="1">0.153</td><td colspan="1" rowspan="1">+0.084</td><td align="char" colspan="1" rowspan="1">11.1</td><td colspan="1" rowspan="1">&#8722;1.79</td><td align="char" colspan="1" rowspan="1">11.4</td><td colspan="1" rowspan="1">&#8722;1.8</td><td colspan="1" rowspan="1">+2.0</td></tr><tr><td colspan="1" rowspan="1">5</td><td colspan="1" rowspan="1">153</td><td colspan="1" rowspan="1">&#8722;36</td><td colspan="1" rowspan="1">0.122</td><td colspan="1" rowspan="1">&#8722;0.064</td><td colspan="1" rowspan="1">4213.4</td><td colspan="1" rowspan="1">+2257</td><td colspan="1" rowspan="1">318.4</td><td colspan="1" rowspan="1">+207.0</td><td colspan="1" rowspan="1">0.464</td><td colspan="1" rowspan="1">&#8722;0.352</td><td align="char" colspan="1" rowspan="1">8.5</td><td colspan="1" rowspan="1">&#8722;1.71</td><td align="char" colspan="1" rowspan="1">11.6</td><td colspan="1" rowspan="1">&#8722;2.5</td><td colspan="1" rowspan="1">+0.6</td></tr></tbody></table></table-wrap>The Adapt study aims, pre-post design, data collection protocol and methods for determining saliva osmolality, RBC K:Na, half-life of water in the body and body weight change are described elsewhere <xref rid="b0160" ref-type="bibr">[32]</xref>, <xref rid="b0155" ref-type="bibr">[31]</xref>. After a baseline period, the Adapt study induced increases in drinking water of 1L/d or more above baseline, which were sustained for 4&#160;weeks. Saliva, blood and body weight were measured each week. Each week, saliva and blood were collected 60&#160;min after a 750&#160;ml bolus of drinking water following overnight food and water restriction. The saliva and blood results in this table thus reflect status in the hour after an acute hypotonic challenge, at baseline and after 4&#160;weeks of sustained higher water intake. SGK1: Human SGK1 gene expression analysis by qPCR. Total RNA from human whole blood was isolated using PAXgene Blood miRNA extraction kit, according to the manufacturer&#8217;s instructions. RNA concentrations were estimated by Nanodrop. Equal amounts of RNA were <italic toggle="yes">retro</italic>-transcribed to cDNA using cDNA synthesis kit (Bio-Rad). The resultant cDNA was used as template in quantitative PCR reactions containing SYBR-green fluorescent dye (Bio-Rad). Human SGK1 relative expression levels were calculated using the 2^<sup>-delta</sup> Ct method. Human actin (hActin) expression was used for SGK1 normalization. Target primer (5&#8242;-3&#8242;) sequences for SGK1 were TTC TCT TTC CAG ACT GCT GA and TGG ATG TTG TGC TGT TGT GT and for hActin: CAC CAA CTG GGA CGA CAT and ACA GCC TGG ATA GCA ACG. Plasma VEGF: vascular endothelial growth factor was determined by MyBiosource ELISA No. MBS2886894 by ProNovus Biosciences, Menlo Park, CA, USA. RBC GPX: Red blood cell glutathione peroxidase was determined by assay No.703102, Cayman Chemical, Ann Arbor, MI, USA. Saliva AQP5 was determined by Lifespan Biosciences ELISA No. LS-F4078 by ProNovus Biosciences, Menlo Park, CA, USA.</p></sec></back></article></pmc-articleset>